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Abstract 
Objectives: The overall aim of this thesis was to investigate the precision error, annual 
changes, and monitoring time intervals of muscle and fat outcomes measured by peripheral 
quantitative computed tomography (pQCT), as well as explore the strength of their 
associations with fall status in older adults.  
 
Methods: Participants aged >60 years old (N=190) were recruited from the Saskatoon 
Cohort of the Canadian Multicentre Osteoporosis Study (CaMOs). The precision error (Root 
Mean Squared Co-efficient of Variation, CV%RMS) of soft-tissue outcomes from previously 
reported pQCT image analysis protocols (n=6) were calculated and compared using repeat 
forearm and lower leg scans collected from a random sub-sample of women (n=35). 
Prospective scans were collected with 1 and/or 2 years of follow-up (n=97) to estimate 
annual changes and monitoring time intervals for pQCT-derived muscle and fat outcomes in 
women. Imaging data and responses from a retrospective fall status questionnaire were 
analyzed to investigate the associations of muscle density, functional mobility, and health-
related factors to fall status for both men and women (n=183). 
 
Results: Precision errors of muscle and fat outcomes ranged from 0.7 to 6.4% in older 
women, however not all protocols were equally precise. Muscle cross-sectional area 
decreased by 0.8 to 1.2% per year, with greater losses in the lower limb. Biological changes 
in muscle area and density may be detected with 80 and 95% certainty within monitoring 
time intervals of 4 to 9 years. The odds of having reported a fall increased by 17% for every 
unit decrease in muscle density (mean 70.2, SD  2.6mg/cm3) after adjusting for age, sex, 
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body mass index, general health status, diabetes, the number of comorbidities, and 
functional mobility. 
 
Discussion: This dissertation demonstrated the potential for pQCT to study changes in 
muscle and fat outcomes in older adults. Both muscle area and density can be precisely 
measured. Observed annual changes in soft-tissue outcomes were small in older adults; 
highlighting the importance of precise measurements to detect changes beyond 
measurement error. Together with the estimated monitoring time intervals, these findings 
can assist the planning of prospective investigations of musculoskeletal health in aging. 
Furthermore, based on the observed independent association between muscle density and 
fall status, monitoring muscle density may further complement the study of musculoskeletal 
health and fall risk in community-dwelling older adults.  
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1! Introduction 
  2 
The proportion of Canadians above age 60 is expected to increase 30% by 2031, almost 
exclusively from a doubling of those beyond age 70 [1]. This historically unprecedented 
demographic shift is not exclusive to high-income countries. Global projections estimate that 
the population of adults older than 60 will reach 2 billion by the middle of this century [2]. 
Thus, the 21st century will be defined by an older global society and factors that impact 
aging human health. The aging process is characterized by a diminished capacity to regulate 
the internal environment of the body [3]. No one is immune from the effects of aging, even 
the most fit masters athletes demonstrate physical decline [4]. Brooks et al. [3] observed 
that while mean life expectancy increased over the last century, the maximum lifespan has 
not changed. Thus, much focus has shifted towards identifying modifiable factors that can 
delay the onset of chronic disease and disability to enhance “successful aging”; the physical, 
psychological, and social success with which adults age [5]. While age affects every 
physiological system in the body, changes in body composition and neuromuscular function 
are of great interest. Age-related redistributions of fat, declines in muscle mass and physical 
function translate into reduced functional capacity to perform activities of daily living, which 
eventually lead to heightened risk of injury and a loss of independence [6].  
Declines in muscle mass and strength among older adults have undergone 
tremendous study since Irwin Rosenberg coined the term “sarcopenia” to describe this 
geriatric phenomenon [7,8]. Initial operational definitions exclusively focused their attention 
on measuring muscle mass using Dual energy X-ray Absorptiometry (DXA) [9]. As this realm 
of health research matured, the importance of also measuring fat [10,11], strength [12], and 
physical function gained traction [13-15]. Although there are several variations in how 
sarcopenia is defined [7], many of these definitions are prospectively associated with 
increased likelihood of mobility impairments [16,17], falls  [18-20], and fracture risk [21,22]. 
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Furthermore, evidence suggests a connection between muscle adiposity and physical 
function [23-25]. Both heightened adiposity and reduced physical function have been 
identified as major components of the risk of disability development in older adults [26,27]. 
Adiposity refers to the presence of adipose tissue, which exists throughout the body in 
various regions and quantities. Of these regions, the adiposity of muscle or “myosteatosis” is 
of particular interest due to reported increases with age, regardless of changes in body 
weight and the quantity of subcutaneous adipose [28]; as well as associations with 
hospitalization [29], and hip fracture incidence [30,31].  
Sarcopenia and muscle adiposity are also of special interest to the field of Kinesiology. 
Resistance exercise has long been a recommended treatment for adults with low muscle 
mass [32]. Accumulating evidence in exercise physiology suggests that cardiovascular and 
resistance exercise may be promising countermeasures for reducing muscle adiposity in 
older adults. Cardiovascular exercise has been demonstrated to be effective for the 
reduction of non-myogenic satellite cells, as well the adiposity of older rat gastrocnemii [33], 
and there is recent evidence of a similar adiposity reduction in older humans [34]. 
Furthermore RCTs of aerobic, strength, flexibility and balance exercise regimens maintained 
muscular strength, improved physical function, and prevented or reversed decreases in 
muscle tissue attenuation (a surrogate of adiposity) in the elderly [35,36]. Progressive 
resistance training has also demonstrated positive effects in a small group of elderly men 
and women; significant concomitant changes were observed in thigh muscle attenuation and 
muscle strength with detraining, as well as increases with retraining [37], suggesting a 
connection between muscular fitness and adiposity. Observational data also supports the 
existence of a relationship between muscle function and adiposity, and the specificity of 
adipose depot location. Thigh muscle attenuation, a computed tomography (CT) measure of 
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muscle adiposity predicted isokinetic quadriceps muscle torque, independent of age, race 
and the size of inter-muscular and subcutaneous fat depots [23]. Persons in the lowest 
quartile of muscle attenuation were reported to be 50 – 80% more likely to develop mobility 
impairments, independent of baseline muscle size, strength, and total body fat mass [24]. 
Although the pathophysiology of changes in body composition and neuromuscular function 
observed with age are not fully understood [32], medical imaging provides a non-invasive 
avenue for their study in vivo [38].  
Research concerning soft tissues and the age related changes that occur in human 
muscular and/or functional performance is particularly intriguing [39]. There are several 
imaging methods available to study muscle and adipose tissue depots in vivo [38,40]. 
Among these tools, pQCT is a desirable technology for assessing limb muscle area, density, 
and subcutaneous adipose tissue (SAT) area (Figure 1). When compared to alternative 
radiographic tools, such as DXA and CT, pQCT exposes participants to substantially lower 
effective doses of radiation [41,42]. Originally designed for measures of trabecular bone 
density [43], pQCT is also becoming a popular research tool for the measurement of soft 
tissues in aging research [27,44-56]. Particularly interesting are the findings of the InChianti 
study, which demonstrated pQCT-derived muscle density’s association with motoneuron 
axonal degeneration [46], frailty [45], and incident disability [27]. Significant differences 
were recently reported in pQCT-derived lower leg muscle density when comparing female 
fallers to non-fallers [53], and wrist fracture patients with healthy controls [54]. Falls are a 
major public health concern for the elderly, responsible for over 90% of hip fractures, and 
65% of hospitalizations [57,58]. Given the significance of falls, and the overlapping evidence 
suggesting a potential connection to muscle adiposity [26,29-31,53], further investigation
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Figure 1: Positioning a participant for pQCT scanning of the forearm (A1) and lower leg (A2). Scans provide 
quantitative axial images of fat, muscle, and bone tissues at both the forearm (B1) and lower leg (B2) allowing 
for the study of how the size and composition of these tissues change and relate to human health. 
of the association between pQCT-derived lower leg muscle density and fall status is 
warranted. However, there are multiple image analysis protocols reported (Table 1) and no 
consensus on how to best analyze pQCT scans for the derivation of soft-tissue outcomes, 
including muscle density. This makes it difficult to compare results between studies, as 
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values are dependent on how the images are segmented into fat, muscle and bone. 
Furthermore, there is a lack of precision error data (derived using International Society for 
Clinical Densitometry (ISCD) guidelines) for pQCT-derived soft-tissue outcomes, as well as 
estimates of the longitudinal sensitivity of these outcomes in aging adults. The magnitude of 
biological change necessary to exceed the precision error of the instrument, as well as the 
length of time to observe these changes are important data for the efficient design of 
prospective studies.  
Therefore the aim of this dissertation was to investigate the precision of pQCT image 
analysis protocols for muscle and fat outcomes in older adults, estimate the annual changes, 
and monitoring time intervals [59] for these outcomes, and explore their associations with 
fall status in a sample of community-dwelling older adults. To achieve this aim, three sub-
studies were conducted utilizing data collected from the Saskatoon cohort of the CaMOs. 
Study one utilized a subset of repeat scans collected from older women to compare 
previously reported image analysis protocols for muscle and fat outcomes. Study two pooled 
imaging data collected one and two years apart to estimate annual changes and monitoring 
time intervals for muscle and fat outcomes in older adult women. Finally, study three 
explored the associations between muscle, fat, health related factors and functional mobility 
to fall status. 
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 Table 1: Summary of Reported pQCT Muscle and Fat Image Analysis Protocols 
Ref First    Age Range or   Contour Density Ranges 
 
  
 [#] Author Year Mean (SD)  Software Modes Fat Muscle ROI Filters Precision 
[44] Cesari 2004 74.8 (6.8) BonAlyse N/A  15 to 179    
[60] Bechtold 2005 15.3 (2.5) Stratec XCT  <20 20 to 79    
[45] Cesari 2006 74.8 (6.8) BonAlyse N/A  15 to 179    
[46] Lauretani 2006 21-96 BonAlyse N/A  15 to 179    
[61] Fricke 2008 54.4 (4.1) Stratec XCT  <20 20 to 59    
[62] Fricke 2008 5-19 Stratec XCT  
<20 20 to 59   Yes 
[63] Fricke 2008 5-19 Stratec XCT  
<20 20 to 59   Yes 
[64] Frotzler 2008 41.9 (7.5) Stratec XCT       
[47] Miljkovic-Gacic 2008 40-91 Stratec XCT       
[48] Miljkovic-Gacic 2008 18-103 Stratec XCT      Yes 
[65] Schweizer 2008 7.3 (2.7) Stratec XCT  1 to 29 30 to 69   Yes 
[66] Cesari 2009 74.5 (7) BonAlyse N/A  15 to 179    
[67] Coupaud 2009 40 (C.S.) Stratec XCT  <36 36 to 279    
[68] Coupaud 2009 35-41.2 Stratec XCT  <36 36 to 279    
[69] Dubner 2009 5-22 Stratec XCT      Yes 
[70] Ducher 2009 8.4 (0.4) Stratec XCT CM3/PM1 -39 to 39 40 to 279   Yes 
[71] Ducher 2009 7-10 Stratec XCT  -39 to 39 40 to 279   Yes 
[72] Eser 2009 18-44 Stratec XCT CM3/PM1 -39 to 39 40 to 279    
[73] Fricke 2009 5-19 Stratec XCT  
<20 20 to 59   Yes 
[74] Fricke 2009 5-19 Stratec XCT  
<20 20 to 59   Yes 
[75] Frotzler 2009 38.6 (8.1) Stratec XCT       
[76] Martin 2009 4-12 Stratec XCT  <30 30 to 69   Yes 
[77] Sergi 2009 24-57       Yes 
[78] Sherk 2009 18-30 Stratec XCT CM3/PM1 -100 to 39 40 to 710  F03F05 Yes 
[79] Wetzsteon 2009 5-21 Stratec XCT      Yes 
[80] Wetzsteon 2009 9-12 Stratec XCT      Yes 
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[81] Bechtold 2010 12.2 (2.7) Stratec XCT  <30 30 to 59    
[82] Bechtold 2010 6-21 Stratec XCT      Yes 
[83] Eser 2010 20-90 Stratec XCT  -39 to 39 40 to 279    
[84] Leonard 2010 5-35 Stratec XCT  <40 40 to 710   Yes 
[49] MacIntyre 2010 52-87 Stratec XCT CM3/PM1 <40 40 to 279    
[85] Sherk 2010 18-64 Stratec XCT     
F03F06U
01  
[86] Swinford 2010 26.6 (8.7) Stratec XCT CM3/PM2 -100 to 39 40 to 710 Box 7x7 ISCD 
[50] Farr 2011 10.7 (1.1) Stratec XCT BDI -100 to 39 40 to 149 Box BDI Yes 
[87] Micklesfield 2011 13 (0.2) Stratec XCT CM3 <40 40 to 179    
[88] Sherk 2011 24-49 Stratec XCT  -100 to 39 40 to 710  Multiple Yes 
[89] Sukumar 2011 25-71 Stratec XCT CM1/PM1      
[90] Szabo 2011 42 (16) Stratec XCT  -100 to 39 40 to 710 Matrix  Yes 
[91] Talla 2011 68 (11) Stratec XCT  -39 to 39 40 to 279   Yes 
[92] Wetzsteon 2011 5-35 Stratec XCT      Yes 
[93] Butner 2012 38.6 (4.7) Stratec XCT CM3/PM1 <40 40 to 279 Box F03F05 F05/F07 ISCD 
[51] Farr 2012 10.7 (1.1) Stratec XCT BDI -100 to 39 40 to 149 Box BDI ISCD 
[94] Loenneke 2012 22 (3) Stratec XCT     
F03F06U
01 Yes 
[95] Mostoufi-Moab 2012 5.1-25.5 Stratec XCT      Yes 
[96] Putzker 2012 19.7 (0.5) Stratec XCT       
[97] Sayers 2012 15.5 (0.3) Stratec XCT     
F03F05 
F05/F07 Yes 
[98] Van-Caenegem 2012 38 (8) Stratec XCT  <60 60 to 279    
[52] Baker 2013 21-78 Stratec XCT BDI -100 to 39 40 to 149 Box BDI Yes 
[99] Deere 2013 17.8 (0.4) Stratec XCT     
F03F05 
F05/F07  
[100] Farr 2013 10.7 (1.1) Stratec XCT BDI -100 to 39 40 to 149 Box BDI Yes 
[101] Laing 2013 18-19 Stratec XCT CM3/PM1  34 to 279 Manual   Yes 
[102] Loenneke 2013 23 (3) Stratec XCT      Yes 
[103] Mueller 2013 43.8 (5.5) Stratec XCT   35 to 710   Yes 
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[104] Rantalainen 2013 23 (5) BoneJ N/A -40 to 40 41 to 199 Matrix 7x7 median Yes 
[105] Rittweger 2013 31 (6) Stratec XCT N/A N/A N/A Manual  None Yes 
[106] Vandewalle 2013 10-19 Stratec XCT  <40 40 to 279    
[107] Veilleux 2013 6-60 Stratec XCT   40 to 279    
[108] Blew 2014 9-13 Stratec XCT BDI -100 to 39 40 to 149  BDI Yes 
[109] Stagi 2014 23.1 (6.2) Stratec XCT       
Abbreviations: SD = Standard Deviation; ROI = Region of Interest; BDI = utilized Bone Diagnostics Incorporated protocols; ISCD = derived using 
International Society for Clinical Densitometry guidelines; CM1/3 = Stratec XCT Contour Mode 1/3; PM1/2 = Stratec XCT Peel Mode 1/2; C.S. = 
Case Study. 
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2! Review of Literature 
  11 
To establish a conceptual framework for investigating the precision and annual changes of 
pQCT-derived muscle and fat outcomes as well as their relationship with fall status, a 
discussion of the following topics is necessary: In vivo imaging of muscle and fat, sarcopenia, 
myosteatosis, neuromuscular aging, and falls in older adults. The aim of this chapter is to 
summarize these relevant topics and concepts to provide the framework upon which the 
purpose of this dissertation was established. 
2.1!  Imaging Muscle & Fat  
Longitudinal research has demonstrated that after age 45, adults lose approximately 12 to 
17% of thigh muscle strength per decade, a change that is partly related to the loss of 
muscle mass [110]. Objective, imaging based measurements of muscle and adipose tissues 
are central to the study of sarcopenia and aging because they do not vary with arthritic pain 
or patient motivation. Furthermore, precise imaging outcomes are sensitive to subtle 
changes in soft-tissues that can help us better understand pathology, even before these 
changes manifest in clinical outcomes [111,112]. Although DXA measures of appendicular 
lean mass are commonly used to quantify muscle as a primary technique among definitions 
of sarcopenia, there is no expert consensus on methodology for routine assessment of 
skeletal muscle [113]. Furthermore, the need for data obtained from more sophisticated 
imaging techniques that are able to discern secular changes in soft-tissues has been a 
recent subject of much methodological discussion in muscle aging and sarcopenia research 
[38,40,112,114]. Although there are promising advanced MRI methods under development 
to provide in vivo measures of mitochondrial energetics [38,115], muscle creatine [38], and 
muscle fibre orientation [38,116], they are largely out of the scope of this dissertation. To 
reflect the evidence discussed in this literature review, this section will focus primarily on 
methodological aspects of the precision and monitoring of muscle and fat outcomes, as well 
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as soft-tissue measures derived from DXA, clinical CT, anatomical and proton spectroscopic 
MRI outcomes, and pQCT methods.  
2.1.1! Precision and Monitoring of Imaging Outcomes 
Understanding the precision error of a measurement tool is necessary to know if apparent 
changes in an outcome are real, or simply a reflection of noise due to analytical and 
biological variation [117]. Furthermore, a technique’s longitudinal sensitivity (ability to 
monitor changes) is limited by its precision error [59]. Longitudinal evaluation seeks to 
determine three things: 1) Meaningful and clinically relevant changes; 2) The time interval 
that allows accurate assessment of treatment response or disease progression; and 3) The 
technique best suited to detect changes quickly and accurately [59].  
Precision errors calculated with less than 27 degrees of freedom, or the use of 
arithmetic means (compared to root mean squared averages) may underestimate the true 
imprecision by up to 41% and 25% respectively [118]. An accurate (defined as 90% certainty 
of being within 30% of the actual error value) assessment of the precision error of an 
imaging technique requires the calculation of the root of the mean squared differences from 
measurement pairs with at least 27 degrees of freedom (i.e. 27 participants measured 
twice) [118]. These recommendations have since been adopted by the ISCD [41,119], which 
now hosts a convenient web-based precision calculation tool, and recommends repeat 
measures from at least 30 individuals [120]. Precision errors may be expressed as absolute 
values (root mean square standard deviation; SDRMS) or as a percentage of the sample mean 
CV%RMS [118]. See Appendix D for a worked example of the calculation of these values.  
To characterize longitudinal sensitivity, the responsiveness of the outcome to change 
needs to also be taken into account [59]. Precision error, together with median annual 
changes, can be used to estimate monitoring time intervals (MTIs) between measurement 
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occasions. MTIs provide a time estimate (in years) to reliably (with 80% and 95% certainty) 
detect changes in disease progression or treatment effect. The calculation of these intervals 
allow for follow-up measures to be efficiently performed within the optimal window for 
capturing true biological change in imaging outcomes, and minimize both the radiation 
exposure to participants as well as the costs associated with repeated scanning in 
prospective studies [59]. To calculate these estimates of longitudinal sensitivity, we must 
first derive Least Significant Change (LSC) values which are described as the “criterion for 
the smallest change between two measurement results that can be considered statistically 
significant with 80 or 95% confidence” [59]. A change less than an 80% LSC is not 
considered clinically relevant, and a change less than the 95% LSC is not statistically proven 
[59]. The LSCs are calculated similarly by multiplying the precision error by √2 times the 
critical Z-value for the desired level of confidence (1.28 and 1.96) [59,117]. To obtain MTIs 
the LSC values are divided by an outcome’s median response (per unit of time) [59].  
Because precision error can vary with the unique characteristics of each participant, it 
should be specific to the population under study [118]. Technique precision derived from a 
young, healthy convenience sample may not be appropriate when assessing values derived 
from an aged or diseased population. Furthermore, precision values should be determined 
from measures collected on separate days but close enough together to negate possible 
biological changes. Same-day image collection has been known to underestimate precision 
errors for muscle and adipose tissue area due to enhanced technician recall when 
repositioning participants, and/or failure to capture between-day fluctuations in the precision 
error of the scanner [86]. Sample heterogeneity can also affect longitudinal estimates of an 
outcomes median response, therefore MTIs for populations with different characteristics, i.e. 
healthy normal, diabetic, etc., should be calculated separately [59].  
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2.1.2! Fat and Adipose Tissue Outcomes 
In the study of body composition and metabolism, “fat” and “adipose tissue” are distinct 
[121].  At the molecular level fat is usually lipid in the form of triglycerides, and although 
adipose tissue contains ~80% fat, it also has water, protein and mineral components, and 
secretes adipokines that interact with surrounding tissues [121]. The terminology used to 
describe various adipose-tissue outcomes varies with the technique utilized, as well as the 
field of study. Komolka et al. [122] provides an excellent overview of the terminology used 
for various types of adipose tissue and fat in human, rodent, and livestock literature and 
provides a visual example of each (Figure 2). In the human limb the following depots are 
studied using direct and surrogate imaging measures: SAT, inter-muscular adipose tissue 
(IMAT), intramuscular fat (IMF); consisting of adipocytes within muscle, extramyocellular 
lipids (EMCL) and intramyocellular lipids (IMCL). DXA measures separate fat mass from lean 
mass for the total body, which can also be analyzed into sub-regions for estimates of central 
fat mass, and limb fat and lean mass, but cannot provide information about intra-tissue fat 
(IMAT, EMCL, IMCL) [40,112,114]. Both SAT and IMAT areas can be estimated using MRI 
and CT techniques [123]. While only MRI proton (H1)-spectroscopy can directly measure 
IMCL and EMCL in vivo, CT muscle attenuation serves as a surrogate measure of IMCL and 
EMCL not accounted for by measures of IMAT [124,125]. CT Tools such as pQCT are 
calibrated differently and report tissue properties in density values rather than attenuation. 
Outcomes reported in this dissertation include commonly reported pQCT-derived soft-tissue 
measures: muscle, SAT, and IMAT cross-sectional areas (cm2), as well as muscle density 
(mg/cm3). 
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Figure 2: Illustration of different muscle-related adipose tissue depots. (A) Deep subcutaneous adipose tissue 
(dSAT) covering M. serratus dorsalis, inter-muscular adipose tissue (IMAT) between M. intercostalis interni and 
M. longissimus dorsi, and intramuscular fat (IMF) within M. longissimus dorsi in cattle. (B) Cellular structure of 
IMF in M. longissimus dorsi (cattle, Eosin stained). (C) Intramyocellular lipids (IMCL, red dots, Oil-red O stained) 
in a muscle cell (M. longissimus dorsi, mouse). Reprinted with permission from Komolka et al.  [122] and The 
Journal of Genomics. 
Muscle area is related to contraction torques [126], SAT and IMAT area quantify the 
adipose in subcutaneous and inter-muscular depots, and muscle density provides an 
analogue of muscle attenuation, estimating both adipose [55] and fat [127]. These 
outcomes reflect the unique limitations of the pQCT scanner. Unlike CT (Figure 3) and MRI, 
pQCT does not have a high enough contrast to separate the individual muscles of the 
forearm and lower leg (Figures 4 & 5), both muscle area and density are measures that 
quantify all soft tissues (including muscle, IMAT, EMCL, IMCL) between the inner edge of the 
SAT and the outer edge of the bones.  
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2.1.3! Dual energy X-ray Absorptiometry 
DXA-derived lean and fat mass (g/cm2) parameters are some of the most commonly utilized 
measures in modern body composition research. The DXA scanner uses a projection imaging 
technique with two different energy beams to differentiate soft tissues from bone [128]. 
Thus, the tissue densities are not true volumetric densities, but are areal bone mineral 
densities (aBMD), with an area based unit “g/cm2” calculated by dividing the bone mineral 
content by bone area [41,128]. DXA can also separate mineral free soft tissue (lean mass) 
from fat mass, and appendicular lean mass has become a central component of the 
operational definitions of sarcopenia [7]. Be that as it may, the accuracy of DXA lean and fat 
mass measures are not well established, and have been shown to vary inconsistently with 
body type [129,130]. In obese adults, DXA underestimates fat mass when compared with 
computed tomography, and this bias has been shown to increase in heavier participants 
[130]. 
The advantages of DXA are the ability to quantify whole body fat and lean mass, and 
the comparatively low radiation doses associated with the technique. Limitations include an 
inability to provide tissue-specific lean and fat mass, (e.g., subcutaneous from visceral or 
muscle adipose), as well as the increased errors in lean and fat mass estimates that can 
occur if a patient is excessively under or overweight [128,131]. Furthermore, it may prove 
impossible to properly position a participant for a scan if they are kyphotic and cannot lay flat 
on the scanner table [128]. Newer scanner models have demonstrated better precision 
(CV%RMS of 1.2 to 1.6%) for determining the lean mass arm and leg sub-regions in younger 
and mixed-age, healthy samples [132,133]; however, poorer appendicular lean mass 
precision (CV%RMS of 2.7 to 10.9%) has been reported for older scanner models and aging 
cohorts [134].    
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2.1.4! Magnetic Resonance Imaging & Spectroscopy 
Magnetic resonance techniques are among the cutting edge of body composition imaging. 
Although new techniques are being developed that will provide muscle health and function 
data beyond anatomical tissue sizes and volumes [38], the principal use of magnetic 
resonance imaging (MRI) in musculoskeletal research has been to characterize the quantity 
and distribution of fat and muscle tissue [38,135]. Unlike DXA and CT methods, MRI does 
not utilize ionizing radiation, which allows for the measurement of muscle and fat properties 
throughout the entire body and across the human life span (from fetus to cadaver). Whole 
body 3D composition scans are able to monitor changes in the various depots of fat, allowing 
for the study of the redistribution of fat and its pathophysiological implications [136]. MRI 
scans can also provide a quantitative assessment of myocellular lipid via magnetic 
resonance spectroscopy (MRS) analyses with the use a radio-frequency coil tuned to H1 
[135]. In addition to quantifying IMCL, this technique can also identify triglycerides existing 
within and outside of the muscle fibres (EMCL) [125]. Conventional MRI often only measures 
the cross-sectional areas or volumes of large stores of inter-muscular adipose tissue 
[38,135]. The ability of MRI to measure muscle and adipose cross-sectional areas has been 
validated with cadaveric specimens with a precision (CV%) of ~2% [123], and muscle lipid 
content via H1-spectroscopy has been cross-validated with CT attenuation [125]. Substantial 
cost, limited availability, and poor standardization of imaging protocols are the primary 
limitations of this technique.  
2.1.5! Computed Tomography 
Similar to MRI, computed tomographic imaging is also capable of providing 3D images of the 
soft-tissues of the body. CT can provide estimates of muscle size as well subcutaneous, 
visceral, inter-muscular fat depots [123]. Furthermore, muscle attenuation (Figure 3) 
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provides an imaging-based analogue of IMCL and EMCL content [124,125]. The ability of CT 
to assess muscle size and adiposity has also been cross validated with both MRI and 
magnetic resonance spectroscopy [123,125]. Goodpaster, Kelley, et al. [124] demonstrated 
that muscle attenuation values have a near perfect linear association with lipid content in 
vitro. Furthermore in vivo muscle attenuation values were negatively associated with muscle 
biopsy lipid and triglyceride content [124,125].  
The methodological variability (CV%) of muscle attenuation was found to be less than 
1% for both the mid-calf and mid-thigh [124], but this CV% was calculated from repeat 
measures of only 6 volunteers and likely underestimates the true precision error of these CT 
measurements. The Health, Aging and Body Composition (Health ABC) study has generated a 
wealth of data demonstrating the value of CT muscle imaging in aging research [29,30,137-
142]. Muscle attenuation and adipose tissue area are associated with a number of different 
functional [23,24,26], clinical [30,31] and public health [29], outcomes in older adults.  
Although clinical CT scanners allow for imaging in any part of the body, the technology 
has limited feasibility for large-scale use. Clinical scanners are expensive, and while the 
radiation dose associated with their use varies with the scan protocol, it is among the 
highest of all radiological imaging techniques [143]. For these reasons, a smaller-scale CT 
cousin “pQCT” has also become a popular tool in musculoskeletal health research.  
2.1.6! Peripheral Quantitative Computed Tomography 
Peripheral Quantitative Computed Tomography technically refers to any QCT scan of 
the periphery of the body. Despite that, a set of devices dedicated to this function have 
usurped this terminology in the literature [41]. The acronym “pQCT” most often refers to a 
class of small step-and-scan QCT tools [143,144]. These scanners collect axial tomographic  
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Figure 3 : Representative CT images of the midthigh showing in black the outline of the region of interest 
encompassing the thigh muscle bundle used for area and attenuation measurements. (a) Axial image showing 
extensive fatty infiltration of the muscle and having a thigh muscle lean tissue attenuation coefficient of 26 HU. 
(b) Axial image with a thigh muscle lean tissue attenuation coefficient of 38.6 HU. Reprinted with creative 
commons licensing from Lang et al. [30]. 
slices with a thickness of 2.1 to 2.5mm, through 15-30 translations of 12 degrees around a 
limb [144,145]. Scanners are factory calibrated to the European Forearm Phantom, which 
consisted of a water equivalent soft tissue simulating material [42,146,147]. Thus, contrary 
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to CT attenuation values (HU), pQCT quantifies all tissues in terms of volumetric bone 
mineral density (BMD, mg/cm3), measured in milligrams of hydroxyapatite per cubic 
centimeter and calibrated with fat equal to 0 mg/cm3 and a resin based water-equivalent 
material as 60 mg/cm3 [143,146,147]. Relative to clinical CT devices, pQCT scanners are 
more compact, cost-effective, and expose participants to substantially lower effective doses 
of radiation [143]. With the exception of Single Photon Absorptiometry, pQCT emits the 
lowest effective dose of all densitometric techniques [42,143]. Similar to a full body CT 
scanner, pQCT is also able to image fat, muscle, and bone to determine tissue content, 
density, and area. However, pQCT is limited to scanning the arms and legs, and does not 
provide enough contrast to distinguish individual muscles. Thus, pQCT derived lower leg and 
arm muscle density and cross sectional area provide global measures of appendicular 
muscle. Furthermore, scanner resolution restricts the ability to measure thin structures due 
to partial volume effects [148].  
Along with relatively low radiation doses, pQCT provides the advantages of being able 
to separate appendicular SAT from muscle, as well as provide precise measures of muscle 
size, density and SAT area. The precision error (CVRMS%) of these measurements range from 
0.7 to 6.5% in the forearms and lower legs of older women [149]. Measures of pQCT-derived 
muscle and SAT area have been demonstrated to be similar to those obtained using MRI; 
although, pQCT image analysis protocols and filtering methods can influence the agreement 
between these two techniques [88]. Research in lemmings demonstrated pQCT-derived liver 
attenuation values accounted for 96% of the variance in chemically extracted liver lipid 
content [127]. In a cross-validation study, MRI-derived IMAT accounted for 50% of the 
variance in pQCT-derived muscle density [55], the remaining unexplained variance may be 
accounted for by other muscle tissue properties, and stores of EMCL, and IMCL that exist 
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below the resolution of the MRI scanner. Measures of pQCT-derived IMAT are not well 
described in the published literature [48,93]. Some evidence suggests large precision errors 
for pQCT-derived IMAT [93], yet there currently is no context (i.e., annual change data) within 
which these precision errors can be evaluated. Fat and muscle methods are an area of 
development for pQCT, and methodological heterogeneity currently limits the comparison 
and pooling of results. Various threshold values, software suites, and image filters (Table 1) 
have been applied to derive muscle and fat measures [45,52,53,88,93,104,149-151], but 
there is no consensus on how to best define these tissues and few methodological 
comparisons exist [149,151]. 
2.2! Sarcopenia 
The term sarcopenia is derived from the Greek sarx, meaning “flesh”, and penia “loss”. The 
term was originally coined in 1988 by Irwin Rosenberg who noted that lean body mass 
underwent the most dramatic and significant decline with age, negatively affecting 
metabolism, ambulation, mobility, and independence [152]. A decade later, Baumgartner et 
al. [9] analyzed data from the New Mexico Elder Health Survey and the Rosetta Study to 
establish the first operational definition of sarcopenia. Sarcopenia was defined as a DXA-
derived appendicular skeletal muscle mass index (appendicular muscle mass/height2) less 
than two standard deviations below the mean value for young adults from the Rosetta Study 
[9]. Recognizing both the physiological importance of fat mass in muscle loss [10] and that 
progressive strength loss was outpacing declines in lean mass [153,154], alternative 
definitions have since been proposed. A “sarcopenic obesity” phenotype was defined 
[155,156], to account for the synergistically greater functional decline experienced by 
persons with both sarcopenia and obesity [32]. Be that as it may, there are still difficulties 
with how we define sarcopenia and sarcopenic obesity. When eight different definitions of 
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sarcopenic obesity were compared using data from the National Health and Nutrition 
Examination Survey, the variability among them produced up to a 26-fold difference in 
prevalence [156]. Although no medical consensus currently exists for sarcopenia or 
sarcopenic obesity, the most recent criteria for sarcopenia adjusts lean mass and grip 
strength values for body mass index (BMI) to account for the effect of obesity [15]. Despite 
the variability in how sarcopenia is defined, nearly two decades of research has been 
produced to help us better understand the mechanisms and relationships of age-related 
declines in muscle mass and function [32]. 
2.2.1! Moving Towards a Consensus Definition for Sarcopenia   
Recent efforts have focused their attention on arriving at a consensus for an operational 
definition of sarcopenia [157,158]. In the past five years, six consensus statements have 
been produced with different criteria for the definition of sarcopenia [13-15,159-161]. While 
there is variation among the consensus statements, all of them acknowledge that a 
definition of sarcopenia should include both low muscle mass (defined 3 different ways) and 
a variety of cut-points for poor function measured as gait speed, grip strength, or 6 min walk 
[7]. Among these 6 definitions, the Foundation of National Institutes of Health (FNIH) 
definition is unique as it is the first data-driven criteria for sarcopenia and does not rely on a 
distribution of lean body mass values from young adults [157]. The FNIH analysis defined 
sarcopenia for men and women as hand grip strength below 26 and 16kg, in the presence of 
a DXA-derived appendicular lean mass over BMI ratio of <0.789 and <0.512 [15,157]. A 3-
year likelihood of incident mobility impairment was predicted by both FNIH criteria for low 
grip strength (OR 2.31 [95% CI 1.34 to 3.99]; OR 1.99 [95% CI 1.23 to 3.21]) and low 
appendicular muscle mass adjusted for BMI (OR 1.58 [95% CI 1.12 to 2.25]; OR 1.81 [95% 
CI 1.14 to 2.87]) for men and women respectively [16] 
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2.2.2! Epidemiology 
Data on the prevalence of sarcopenia are dependent on the definition used, and its 
appropriateness for the population described. Estimates based on the European Working 
Group on Sarcopenia in Older People (EWGSOP) criteria range between 5 and 8% in England, 
22 and 23% in Japan, and 33% of nursing home residents [7]. The International Working 
Group on Sarcopenia (IWG) criteria demonstrated a lower prevalence than the EWGSOP 
when compared in a population-based cohort of elderly Taiwanese [162]. The FNIH definition 
was found to be more restrictive than EWGSOP and the IWG, with only 1.3% of men and 
2.3% of women being defined as having sarcopenia [163].  
A recent British analysis compared the EWGSOP and FNIH sarcopenia criteria’s ability 
to determine slowness and difficulties walking on the Timed Up and Go (TUG) test. Low lean 
mass determined using the FNIH criteria was associated with higher odds of mobility 
impairment, yet EWGSOP lean mass was not [17]. Using the EWGSOP criteria, a cohort of 
sarcopenic Italians had a 3-fold increased risk of falls over a period of 2 years [19]. Similarly, 
sarcopenia was shown to increase the odds of being a faller in a cohort of elderly Japanese 
men and women [20]. Sarcopenia has also been demonstrated to have a relationship with 
fall-induced injuries. Sarcopenia predicts incident fractures [21], and improves fracture risk 
prediction when combined with the Fracture Risk Assessment tool [22] in elderly Chinese 
men. 
2.2.3! Mechanisms & Therapies 
Sarcopenia has multiple contributing factors closely tied to age-related changes in 
physiologic function. Identified factors include: mitochondrial dysfunction, neuronal 
degeneration, weight loss, malabsorption, declines in vascular function, low testosterone, 
growth hormone, insulin growth factor 1,  and vitamin D, increased cortisol, and pro-
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inflammatory cytokines such as interleukin-1/6, and tumor necrosis factor alpha, and 
decreased physical activity [7,32,164]. Sarcopenia accelerates with diabetes and insulin 
resistance, due to decreased protein synthesis and increased protein degradation [32].  
Resistance training has proven to be an effective treatment to stimulate protein 
synthesis, increase muscle mass and strength [32,154,161].  The safety and effectiveness 
for resistance exercise has been demonstrated, even in old and frail individuals living in 
nursing home care [165]. Aerobic exercise may also benefit aging skeletal muscle by 
improving insulin sensitivity via the stimulation of GLUT-4 mediated glucose transportation 
[32,166]. Nutritional interventions, particularly leucine-enriched amino acid 
supplementation, have demonstrated potential [7], but larger RCTs are needed to confirm 
these findings [32]. Anabolic hormone therapies have not proven successful and can carry 
safety risks [7,166]. Clinical trials are currently underway for antibodies that modulate 
myostatin, and ghrelin agonists that could increase food intake and release growth hormone 
[7,157]. Nevertheless, the lack of a medical consensus on a definition has created a barrier 
for investment and clinical development of therapies for sarcopenia. The U.S. Food and Drug 
Administration requires proposed therapies to treat diseases or conditions recognized by the 
medical community [158].   
2.2.4! Challenges 
More research is needed comparing definitions of sarcopenia for the medical community to 
definitively determine which criteria has the best predictive ability and arrive at a medical 
consensus [7,157]. The timely and correct identification of sarcopenia or persons who are at 
risk of becoming sarcopenic may play an important role in the success of therapeutic 
interventions. There is a need for earlier detection and intervention in adults exhibiting 
trends in muscle loss. Although DXA-derived appendicular lean mass measurements are a 
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primary component of the majority of sarcopenia definitions, the utility of these DXA 
outcomes for monitoring changes across serial measures of appendicular lean mass is not 
well described. There is also a growing recognition that tools that can better evaluate and 
differentiate more specific body composition features (e.g., muscle area, muscle 
density/attenuation, SAT, IMAT) are necessary for the research and development of 
therapies targeting muscle and physical performance [40,112,114]. 
2.3! Myosteatosis 
Adipose tissue undergoes changes in distribution and function with age. The increased 
infiltration of muscle tissue with adipose and fat has been referred to as “myosteatosis” 
[37,167]. There are several mechanisms that may contribute to myosteatosis. Metabolic 
hypotheses speculate that increases in ectopic fat storage in both visceral and muscular 
sites are a reflection of the diminished ability of subcutaneous fat depots to expand and 
regulate fatty acids in the blood stream [168,169]. This is characterized by a decline in 
subcutaneous fat storage (a depot which is dependent on adipocyte proliferation) and a shift 
towards visceral and ectopic adipose tissue storage (hypertrophy dependent adipocytes) in 
muscle and other organs [169]. Over time, these changes have deleterious effects on 
metabolic homeostasis, and are also often observed earlier in life in obese and diabetic 
populations [170]. Although multiple factors contribute to this phenomenon, the progression 
of fat redistribution in old age is believed to begin with increased expression of pro-
inflammatory cytokines (tumor necrosis factor-α [TNFα] and Interleukin-6 [IL6]) and the 
emergence of senescent pre-adipocytes; two factors which reduce the differentiation of 
active pre-adipocytes into lipid-storing adipocytes [171]. Supporting this relationship, Beasley 
et al. noted that inter-muscular adipose tissue of the thigh was significantly related to 
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inflammation in older adults, and a trend towards lower pro-inflammatory marker 
concentrations was also observed with increased subcutaneous fat [139].   
Data also suggest that myosteatosis may have origins in the aging of muscle tissue. 
Prospective results from the Health Aging and Body Composition Study indicated five year 
increases in inter-muscular adipose tissue area regardless of changes in body weight or 
subcutaneous adipose, suggesting myosteatosis is a consistent characteristic of aging 
muscle [28]. Altered mitochondrial activity and oxidative stress are suspected to contribute 
to increased myosteatosis in the elderly [164,172]. Johannsen et al. reported that muscle 
fibre ATP and O2 consumption did not differ between young and elderly groups; however, the 
elderly demonstrated a trend towards greater oxidative stress, reduced mitochondrial 
respiratory efficiency, and greater muscle adiposity [172]. Both myocytes and neurons 
contain large quantities of mitochondria and are susceptible to oxidative damage.  
The increased failure of motoneurons to reinnervate muscle fibres undergoing 
remodeling [173] may also promote the replacement of muscle with adipose.  
Muscle fibres orphaned by the neuromuscular regeneration process either atrophy or are 
reinnervated by neighbouring motor units [174]. Muscle fibre atrophy can signal the 
fibro/adipocyte progenitors that assist in muscle fibre regeneration to differentiate into 
fibroblasts and adipocytes [175]. There is cellular evidence which suggests that muscle 
precursor cells increase their expression of adipocytic phenotypes with age [176-179]. Data 
from the InCHIANTI study linked α-motoneuron degeneration to muscle adiposity; after 
adjusting for confounding variables, older men and women who had peroneal nerve 
compound muscle action potentials below the clinically relevant threshold of 4mV were 
between 1.9 and 2.4 times greater odds of having a lower leg muscle density more than an 
SD lower than young adult values [46].  
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 Beyond the loss of contractile fibres with age, the chronic and gradual accumulation 
of adipocytes [139,180] and the pathophysiological effects of their pro-inflammatory 
cytokines [181-183] may precede declines in muscular function in aging [182]. Pro-
inflammatory cytokines can promote peripheral insulin resistance [183], muscle catabolism 
[142,181], decrease the production of myofilament proteins [181,182], increase oxidative 
stress, and reduce contractility and strength [142,181].  A heightened inflammatory state 
lowers the anabolic response to resistance exercise, making it more difficult for older adults 
to maintain and build muscle [181,182]. This was recently demonstrated in a study of older 
adult fallers. Participants with higher baseline levels of muscle adipose demonstrated 
blunted muscle quality improvement from 3-months of training in resistance, endurance and 
balance exercises [184].  
Although the mechanisms of myosteatosis are still being elucidated, cross-sectional 
evidence has linked muscle adiposity with muscle strength [23,49], six meter walk and chair 
stand performance [25,185], ascending and descending stairs and the TUG test [185], 
diabetes [47,48], insulin resistance [167], obesity [39], frailty [45], falls [53], wrist and hip 
fracture [30,31,54]. Prospective evidence links muscle adiposity with physical function and 
mobility limitations [24,141,186], incident non-spine fractures [187,188], hospitalization 
[29], disability [26,27], as well as all-cause and cardiovascular mortality [66,189]. Lastly, 
randomized controlled trials in older adults have demonstrated that imaging-based 
measures of muscle adiposity can be decreased with structured exercise [35,36] and 
resistance training [37]. These effects coincided with improved strength [37], and were 
independently related to improved physical function [36]; suggesting measures of muscle 
adiposity have potential as a relevant marker for healthy and successful aging. 
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2.4! Neuromuscular Aging 
Muscle strength has three major components: neural-motor, contractile, and elastic; all of 
which combine to maximize dynamic muscle strength [190]. The neural coordination of the 
contractile and elastic properties of muscle is necessary to achieve efficiency in human 
movement and maximize force production [191]. The integrated control of human movement 
is guided by the central nervous system (CNS). Reflex inhibition can influence the excitability 
of the CNS, which can affect net joint torque [192]. This is particularly an issue for older 
adults with chronic, painful conditions. For example, the arthritic swelling of joint capsules 
are believed to put pressure on the Golgi tendon organs and afferent pain receptors in 
synovial membranes, leading to arthrogenous muscle inhibition [192,193]. Aches and pains 
can also cause neural inhibition of contraction [3,190,193]. Studies of the role of motor unit 
recruitment in maximal voluntary contraction torque with age are equivocal and depend on 
the muscle group [193-196]. Several studies of the knee extensors have demonstrated no 
differences between young and old adults as well as significant impairments in central 
activation with age [195]. A recent longitudinal analysis of 16 healthy older adults found that 
a reduction in neuromuscular activation was significantly associated with declines in muscle 
power [196]. This healthy older cohort was also contrasted with a group of older mobility 
limited adults who demonstrated no change in neuromuscular activation despite losses in 
power, contraction velocity, and muscle area [197]. Interestingly, both healthy and mobility 
impaired groups demonstrated a significant relationship between declines in contraction 
velocity and increases in IMAT [197]. 
Changes in the peripheral nervous system and muscle tissues are also considered to 
be a culprit of age-induced deficits in strength and power. Alpha-motoneurons are the 
efferent nerves that originate in the brainstem or spinal cord and innervate muscle fibres to 
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facilitate the propagation of action potentials to the muscles [191]. Action potentials 
terminating at the end of a motoneuron set in motion a cascade of electrochemical signaling 
within the muscle fibre that results in contraction. An alpha-motoneuron and the fibres it 
innervates are known as “motor units”. With age, a pattern of motor unit remodeling 
becomes apparent [3,164,174,191]. In young healthy muscle, a regenerative cycle of 
denervation, motoneuron axon terminal sprouting and re-innervation occurs without any 
apparent difficulty. Cross-sectional research indicates that into the seventh decade of life the 
normal turnover of synaptic junctions changes and an increase in the loss of alpha-
motoneurons occurs [192,198]. As a result of muscle fibre denervation, neighbouring 
motoneuron axons sprout new terminals in an attempt to assimilate orphaned fibres into 
their motor unit [164]. Myoplasticity allows these orphaned fibres to adapt their contractile 
properties to more closely match those of the adopting motor unit [174]. With age, a pattern 
emerges where a larger number of fibres exist in each motor unit, and the location of these 
innervated fibres, which were previously intermixed throughout the muscle, are now 
clustered closer together. As a consequence of the amalgamation of muscle fibres into fewer 
motor units, force steadiness and fine motor control is also reduced [199]. Among the fibre 
types, fast twitch muscles appear to naturally undergo more neuromuscular junction 
remodeling cycles than slower phenotypes [200]. There also appears to be a preferential 
loss of fast twitch motor units [164]. This is either due to a greater susceptibility of fast 
twitch motoneurons to atrophy, or a reduced ability to sprout new axon terminals and re-
innervate their type II fibres; giving slow twitch motoneurons the upper hand in the 
remodeling process [164].  
The exact mechanisms of denervation are not completely understood. Early cadaveric 
studies highlighted the reduced number and size of alpha-motoneurons in the ventral root of 
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the spinal cord leading to the initial hypothesis that declines in muscle mass and strength 
may be driven by alpha-motoneuron atrophy [201]. Current evidence suggests that 
motoneuron death may not account for all age related deficits. Edstrom, Altun, et al. [173] 
note that lost muscle fibres often appear halted part way through their typical regenerative 
process. Due to their inability to replicate throughout the lifespan, neurons depend on 
maintenance proteins for structural integrity and plasticity. The accumulation of oxidative 
damage over time can impair the proteins that facilitate neuronal plasticity, compromising a 
motoneuron’s ability to sprout new axon terminals and re-innervate muscle fibres [173].  
Oxidative damage to the mitochondrial DNA, and oxidative stress-induced inefficiencies 
in cellular respiration are also hypothesized to be factors in the accumulation of muscle lipid 
[167,172], and inter-muscular fat observed with age. The production of incomplete, or 
inactive enzymes are also observed, and may be a symptom of dysfunctional protein 
production due to age-related genetic damage [3]. This is particularly common to the 
mitochondria, which are more often exposed to reactive nitrogen & oxygen species 
generated through respiration [202]. In muscle, decreases in glycolytic enzymes, and 
mitochondrial mass impact the production of ATP across all fibre types [3].  
Changes in the elastic properties and composition of muscle also play a role in muscle 
performance with age. In the aging lower leg, increased tendon compliance impairs the 
ability of the musculature to rapidly transmit force onto the skeleton [203], and may reduce 
the efficiency of force production [204]. Evidence suggests that muscle power declines at a 
greater rate than strength, with a reported annual loss of 3.5% (compared to 1-2% isometric 
strength) between the ages of 65 and 89 [205]. The age-related leftward shift in the force-
velocity curve of muscle contraction reduces both peak power, and the optimal velocity for 
power production [192]. Thus, deficits in power are more pronounced as the velocity 
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requirements of a task increase [206]. The serious implications of changes in muscle power 
are especially pronounced in tasks which require high velocities of movement, such as 
preventing a fall and recovering one’s balance from a trip [207-209]. As such, muscle power 
has a profound impact on mobility, functional status, and fall risk in older adults. Deficits in 
whole muscle power exist between old and young groups when normalized to whole muscle 
cross sectional area [210]. Decreased muscle attenuation can account for differences in 
strength not attributed to muscle cross-sectional area in older adults [23]. This is suggestive 
of a role of muscular adipose in the specific force of whole muscle in older adults; yet there 
is little research directly investigating this possibility. An MRI study by Hilton, Tuttle, et al. 
[211] demonstrated a significant correlation between IMAT volume and dorsiflexor and 
plantar flexor isokinetic strength and power. Functional comparisons have noted differences 
in the amount of inter-muscular adipose tissues and muscle densities between healthy older 
subjects and older adults with mobility deficits [25,211,212], as well as fallers [53] and 
fracture patients [30,31,54,187,188].   
2.5! Falls 
In Canada approximately 30% of community-dwelling elders (≥65 y of age [WHO 1984]) fall 
each year, and 12% experience multiple falls [213]. Studies in other industrialized 
populations have reported the prevalence of falling to be 28 – 35% of persons over 65, with 
an increase to 32 - 42% of persons 75 and older [214]. Women are more likely to experience 
a fall, and even well-functioning older persons are not immune to fall events [215-217]. The 
experience of a fall can be a cruel event; with consequences that can include serious injury, 
hospitalization, fear, a loss of independence, and fatality [218]. Almost one quarter of fall 
events result in serious injury, half of fallers report developing a fear of falling, and a quarter 
of fallers restrict their activities (shopping, household chores, physical activity) due to this 
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fear [219,220]. Falls are the leading cause of non-fatal emergency room visits [58], and the 
primary cause of hip fractures [57]. In America, falls are estimated to account for 0.53 
million osteoporotic fractures annually [216]. A systematic review of falls and their 
associated costs in the western world estimated the societal burden of falls to account for 
1.5% of all health care costs, with the average cost of a single fall ranging from $1,059 to 
$10,913 USD [221]. These costs can reach as high as $42,840 in severe fall-related injuries 
[221,222]. There is concern that these costs will rise at a greater rate than the growth of the 
elderly population. Age-adjusted data suggests that the rate of fall-induced injury in older 
persons is increasing [223], with an annual increase of 1.3% for men and 0.7% for women 
over the last 27 years [224]. While the case has been made that falls are prevalent and 
costly (for both the victims and society), how fall data are ascertained is fundamental in our 
understanding of these events.  
2.5.1! Definition and Ascertainment of Falls 
How a fall event is defined and interpreted can influence the occurrence of falling reported 
by older adults. Many studies have defined falls differently, some with broad definitions and 
others with definitions intrinsically or environmentally narrowed to exclude falls that occur 
due to specific events (syncope, violence, car accidents, sports, etc.) [214]. In 2005 Hauer et 
al. noted that there were approximately 40 different variations of the definition of a fall in the 
literature; few of which could be combined [225]. The Prevention of Falls Network Europe 
(ProFaNE) sought to address this problem by publishing a fall definition consensus [226]. 
According to the ProFaNE consensus statement, a fall is broadly defined as “any event where 
any part of your body unexpectedly contacted the ground or another lower surface”. 
Utilization of this consensus definition is important for the assembly of comparable fall data, 
which can be pooled to further enhance fall research and health policy [225]. Many fall 
  33 
studies have acquired fall data retrospectively [215,225,227,228], primarily for the 
convenience of collecting fall data in a very short span of time. Prospective methodologies 
are more resource intensive and may include daily record keeping of falls on a falls calendar, 
with weekly or monthly telephone follow-ups [225]. While the reliability of a retrospective 
recall in an elderly population is often a concern, data from a prospective fall monitoring 
study demonstrated that only 13% of elderly men and women failed to recall a fall event in 
the previous 12 months [229], whereas short-term recall was worse (32% and 26%) at 3 and 
6 months respectively. It should be noted that the effect of participation in this prospective 
study was not controlled for, and these recall percentages likely reflect an overestimation of 
recall ability.  
2.5.2! Fall Risk Factors & Muscle Weakness  
Risk factors are variables that may increase the likelihood of experiencing a harmful event 
[230]. The identification and monitoring of these factors is an important aspect of fall 
prevention research [217]. Fall risk factors include muscle weakness, a previous history of 
falls, gait deficits, balance deficits, use of an assistive device, visual deficits, arthritis, 
impaired activities of daily living, depression, cognitive impairment, vitamin D deficiency, 
polypharmacy, and age [218,231,232]. Due to the multifactorial nature of falls it is both 
unlikely and unreasonable to assume that any single physical performance test or biomarker 
will be shown to have excellent predictive accuracy [233]. There presently is no gold 
standard screening test for the prediction of falls in community-dwelling older adults [234]. 
The TUG test (measured as the time required to rise, walk three meters, turn and return to a 
seated position in a chair), was previously recommended for use as the primary falls risk 
screening tool in the joint statement from the American Geriatrics Society and the British 
Geriatrics Society (2001) [232]. Meta-analyses have recently demonstrated the TUG to have 
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poor univariate predictive ability for falls in high-functioning, healthy older people [235,236], 
and it was not recommended as the primary screening tool in the 2011 statement update 
[231].  
 A meta-analysis reported by the American Geriatrics Society and British Geriatrics 
Society provides insight into the relative importance of fall risk factors [218,232]. Muscle 
weakness was the single most important univariate risk factor; elderly persons with muscle 
weakness were 4.4 times more likely to fall than their fit peers [218,232]. History of falls, 
gait and balance deficits produced a mean relative risks of 3.0, 2.9 and 2.9, with other risk 
factors ranging between 2.6 and 1.7 [218,232]. Weakness, gait, and balance appear to be 
inter-related [207,237]. Lower limb muscle weakness is apparent in persons who display 
poor balance, abnormal gait, and reduced mobility [237,238]. A more rigorous meta-analysis 
of only prospectively ascertained falls and muscle weakness in community-dwelling adults 
reported a combined OR of 1.66 [95% CI 1.20 to 2.29] for the association between lower 
extremity weakness and falls [239].  
2.5.3! Fall Prevention 
Almost one in five falls (17%) are believed to be caused by muscle weakness or gait and 
balance disorders, which are second only to environmental hazards (31%) as the primary 
cause of falls [218]. Previously deemed ineffective [240], recent evidence now supports the 
efficacy of home safety assessments and modifications, particularly when delivered by an 
occupational therapist [241]. Carefully managed exercise programs, which target muscle 
weakness, are also an efficacious avenue to reduce the overall risk of falls. Several group 
and individual exercise interventions have reduced falls and fall risk [242] and improved 
lower body and postural strength, balance, flexibility and endurance in the community-
dwelling elderly [241]. Furthermore, a meta-analysis of 59 randomized controlled trials 
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determined that multi-component group and home-based exercise interventions were 
effective in reducing the number of fallers, and the rate of falling [241]. This is also reflected 
in the current clinical guidelines for falls prevention, which recommend that all multifactorial 
interventions for community-dwelling older people have an exercise component that includes 
balance, gait, and strength training [231]. 
2.6! Summary of Literature Review 
The study of factors that influence human health in aging is of paramount importance as the 
world undergoes an unprecedented demographic shift towards an aged society. Changes in 
body composition and neuromuscular health are known to influence the risk of deleterious 
outcomes in old age. Among these changes, sarcopenia, “the loss of muscle mass and 
function”, and myosteatosis “the increased infiltration of muscle with adipose” are two 
phenomenon that share common etiology, and causal relationships with mobility limitations, 
fractures, and falls. Furthermore, muscle mass and adiposity appear to be modifiable targets 
for exercise interventions in older adults. Improved muscle mass and adipose profiles predict 
improvements in the physical function of older adults. The in vivo study of anatomical 
changes in muscle mass and adiposity is partially facilitated by biomedical imaging tools. 
Among these tools clinical CT and MRI offer high-contrast axial images of soft-tissue 
compartments; however, these tools often have limited availability and, in the case of CT, 
have a high effective radiation dose. Commonly utilized DXA imaging provides low-dose 
estimates of total body and appendicular measures of bone, lean and fat mass. Unlike axial 
CT and MRI, DXA cannot measure adipose infiltrating muscle for an assessment of muscle 
adiposity. Peripheral quantitative computed tomography scanners fill a musculoskeletal 
imaging niche between clinical CT, MRI and DXA. Although limited to the extremities, pQCT 
scanners capture axial images and can quantify muscle size & adiposity, as well as SAT in 
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three dimensions with a low radiation dose comparable to DXA scans. There are a variety of 
protocols for the derivation of soft-tissue outcomes from pQCT scans, yet no data currently 
exists comparing the precision error of these methodological variations in older adults.  
Furthermore, the longitudinal sensitivity of pQCT to changes in the soft-tissues of older 
adults has also not been assessed. Determining the most precise image analysis protocols 
for soft-tissue outcomes will facilitate more efficient longitudinal research and optimize the 
estimated observation time required before changes in these tissues can be detected. 
Together this data can extend the utility of pQCT for the study of changes in muscle and fat 
in older adults. Finally, preliminary evidence suggests that low pQCT-derived leg muscle 
density may be a biomarker for fall risk; a clinically relevant event that can precipitate 
serious injury, chronic disability, and loss of independence. The strength of the association 
between muscle density as a bivariate and multivariate predictor of fall status has not yet 
been described. Methodological and exploratory analyses may be able to resolve some of the 
uncertainty that exists around pQCT-derived soft-tissue outcomes, and extend the 
capabilities of this tool for measuring and monitoring muscle and adipose tissues as 
indicators of healthy aging.  
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3! Objectives & Hypotheses 
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3.1! Study One: Comparing the Precision of Reported Protocols 
The objective of study one was to survey the literature and compare the precision of 
previously reported image analysis protocols for quantifying muscle area and density, as well 
as IMAT and SAT area in the commonly imaged lower leg and forearm using repeated pQCT 
images from older, community-dwelling postmenopausal women. The hypothesis was that 
the precision errors would differ across reported pQCT soft-tissue image analysis protocols.   
3.2! Study Two: Estimating Annual Changes and Longitudinal Sensitivity 
The objectives of study two were to assess: 1) the annual changes in pQCT-derived muscle 
area and density as well as IMAT and SAT at both the forearm and lower leg; and 2) estimate 
MTIs for each of the aforementioned muscle and adipose tissue outcomes in older 
community-dwelling women. The hypothesis was that annual changes would be observed in 
pQCT-derived soft-tissue outcomes when monitored over time.  
3.3! Study Three: The Association Between Muscle Density and Falls 
The primary objective of this study was to explore the relationships of muscle density, 
functional mobility, and health-related factors to fall status. The primary hypothesis was that 
muscle density would be independently associated with fall status after controlling for age, 
sex, BMI, general health status, diabetes, the number of comorbidities, and functional 
mobility. The secondary objective was to determine the independent and combined 
relationship of muscle density and functional mobility to fall status after adjusting for health-
related factors. The secondary hypothesis was that models which include both muscle 
density and TUG test time will have a better fit with the data than models that include them 
separately.  
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4! Study One: Measurement of Muscle 
and Fat in Postmenopausal Women: 
Precision of Previously Reported pQCT 
Imaging Methods 
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4.1! Synopsis 
This chapter outlines the methodological details of reported pQCT image analysis protocols 
utilized to derive muscle and fat outcomes in the literature. This chapter also presents a 
comparison of the precision errors inherent to variations in these protocols when analyzing a 
common set of repeat images collected from a random sub-sample of older adult women.  
This chapter has been published as an original investigation article in a peer-reviewed 
journal [149]. With the exception of some minor wording and/or format changes that were 
necessary for the conversion to graduate thesis format, it is presented in its published form. 
The introduction section below may repeat key aspects of the literature review directly 
pertinent to the purpose of the study. 
4.2! Introduction 
For nearly 20 years, pQCT has been used to precisely measure and study volumetric density 
and distribution of bone mineral tissue [41,243]. In more recent years, pQCT has also been 
used to quantify muscle area [126,244], muscle density [45,46,49-51,93,105,245,246], 
subcutaneous adipose tissue (SAT) area [70,72,131], and inter-muscular adipose tissue 
(IMAT) area [48,93]; all valuable measures for the study of musculoskeletal health. These 
measures are important given increased interest in the study of soft-tissues as a factor in 
bone development and health [50,52,100], as well as for studying the development of 
diabetes [47,93,246], sarcopenia [46,114], falls [53], and frailty [45].  
Although pQCT is proving to be a useful tool for measurement of muscle and fat, there 
is limited information regarding precision (i.e., repeatability) of muscle and fat measures in 
older adults. To date, precision errors for pQCT-derived muscle area, density, IMAT and SAT 
area have been reported for children (ages 7-12y) [50,70], young (26.6, SD 8.7y) [86] and 
premenopausal women (38.6, SD 4.7y) [93]. Prior to a recent muscle area and density paper 
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by Wong et al. [151], only lower leg muscle area and SAT precision values had been reported 
for postmenopausal women [90]. Both lower leg IMAT and forearm soft-tissue data have yet 
to be reported for older adults—a population with unique soft-tissue morphometry and a 
clinically relevant risk of muscle loss [114,164] and fat infiltration [28,51].  
In addition to limited muscle and fat precision information, previous studies reporting 
precision errors used different image analysis protocols. Employed protocols have included 
manufacturer recommendations (Stratec Medizintechnik GmbH, Pforzheim, German) 
[247,248], customized manufacturer’s protocols [52,105,249,250], or third-party software 
(e.g. BonAlyse, BoneJ) [45,46,251,252], each with specific segmentation approaches 
capable of influencing precision (e.g., contour detection algorithms, noise reduction filters, 
grayscale intensity thresholds). It is currently unknown which previously reported analysis 
protocols are most appropriate for precisely characterizing muscle area, density, and fat area 
in older adults. This is important because the most precise analysis techniques are required 
for detection of small effect sizes in soft-tissue outcomes. For example, an annual increase 
of 6.5% in CT-derived IMAT was reported in weight-stable older adult women [28]. According 
to the 95% LSC criterion [59], a precision error less than 2.3% (6.5%/2.77) would be 
necessary for detecting a true change or difference with 95% confidence. A precision error 
greater than 2.3% would imply that, due to analysis imprecision, observed (statistically 
significant) changes or differences may not truly exist. As such, identification of the most 
appropriate analysis protocols is of paramount importance for the measurement of soft 
tissues with pQCT. 
Using repeated pQCT images from older, community-dwelling postmenopausal women, 
the objective of this study was to compare the precision of previously reported image 
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analysis protocols for quantifying muscle area and density, as well as IMAT and SAT area in 
both the commonly imaged lower leg and forearm. 
4.3! Methods 
4.3.1! Participants 
Female participants aged 60 years and above were recruited from the Saskatoon cohort of 
the CaMOs; a longitudinal study of the associated factors and burden of osteoporotic 
fractures in a random, population-based sample of Canadian community-dwelling men and 
women. The CaMOs sample was assembled in 1995-1996, and consists of Canadians living 
within a 50km radius of each study centre. Households within each geographic area were 
contacted using a random list of telephone numbers, and one member (>25 y of age, non-
institutionalized) was recruited from each household [253]. A randomly selected sub-sample 
of thirty-five women volunteered for this pQCT precision study (mean age: 73.7, SD 7.2) 
years, height: 159.8 (5.6) cm, weight: 71.9 (12.5) kg, BMI: 28.1 (4.7) kg/m2, SF-36 General 
Health Status score: 80.7 (14.7)). None of the aforementioned characteristics of this sub-
sample were statistically different (P>0.05) from their respondent CaMOs peers (N=115). 
4.3.2! Data Acquisition 
One investigator (AFW) performed repeated pQCT imaging of the forearm and lower legs 
scans an average of 9.7 (3.6) days apart. The non-dominant (self-reported) forearm and 
ipsilateral lower leg were scanned using a Stratec XCT 2000 pQCT scanner (Stratec 
Medizintechnik GmbH, Pforzheim, Germany). A scout scan was performed over both the wrist 
and ankle joint. The scanner reference line was positioned at the most proximal aspect of 
the distal tibia endplate and the medial tip of the distal radius endplate. Images were 
acquired at 66 % of the tibia length and 65 % of the radius length proximal to the reference 
line as previously reported [254]. All images were collected at a scan speed of 20mm/s with 
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a voxel size of 400µm x 400µm x 2.4mm. Stratec XCT scanners are factory calibrated 
against the European Forearm Phantom for a single energy. As such, each scanner 
measures fat, water/lean tissue, and cortical bone with hydroxyapatite equivalent volumetric 
densities of 0 mg/cm3, 60 mg/cm3, and 1200 mg/cm3, respectively [146]. Image quality 
was visually assessed following data acquisition. The scan was rejected and repeated if the 
cortical shell was irregular due to movement artifacts. Using this criterion, one participant’s 
lower leg was rescanned to achieve an acceptable image. The University of Saskatchewan 
Biomedical Research Ethics Board reviewed and approved this research. All participants 
provided written informed consent.  
4.3.3! Image Analysis Selection 
A search of the literature was conducted using Web of ScienceTM 5.13.2 (Thompson Reuters, 
Philadelphia, PA, USA) for journal articles published as recent as March 2014 containing the 
topic terms: (peripheral quantitative computed tomography OR pQCT) AND (muscle OR fat OR 
adipos*) NOT (mice OR rats OR rabbits OR porcine). The resulting 317 abstracts were 
searched for articles that used pQCT to study muscle or fat in humans, which were then 
retrieved for a review of their methodology. We focused this analysis on unrestricted 
software resources: Stratec XCT (supplied with every scanner), and the freely available 
BoneJ, a software plugin for the open source ImageJ image analysis software 
[150,252,255]. These software resources were used in 93% of the retrieved abstracts. Six (I-
VI) protocols were identified that were reported with reproducible details for application. 
These protocols were not exclusive, but they were described in sufficient detail to be 
replicated and applied to a set of 35 repeat scans in women aged 60-90 y. Five protocols 
relied on Stratec XCT (manufacturer’s software) and one used the pQCT Density Distribution 
tool in BoneJ:  
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I)! Modified Stratec recommendation A – Muscle Smooth Filter 3 (with added -40 fat 
threshold) [49,70,71,93,247] 
II)! Stratec recommendation A – Muscle Smooth Filter 2 [247] 
III)! Stratec recommendation B - Muscle Smooth Filter 2 (with manual bone regions of 
interest (ROI)) [53,126,248,250,256-258] 
IV)! Bone Diagnostic Incorporated [50-52,100,249,259] 
V)! Manual Segmentation [105] 
VI)! BoneJ [104,251,252,255] 
 
As automated contour detection algorithms do not always succeed in correctly 
identifying tissue boundaries, all image analyses were visually inspected for errors using the 
CALCBD/CORTBD functions in Stratec XCT and the visual result saved by BoneJ.  
4.3.4! Stratec XCT Protocols 
The details of the placement of ROIs, contour modes, thresholds, filters employed, and 
outcomes produced for each of the analysis protocols are summarized in Table 2. A variety 
of median filters with NxN mask sizes of 3x3, 5x5, and 7x7 are combined by Stratec XCT to 
reduce noise and aid contour detection. According to the Stratec XCT manuals, Contour 
Mode 1 acts by removing all image voxels below a set density threshold, whereas Contour 
Mode 3 is an iterative algorithm that searches for a gradient of difference between voxels to 
define the existence of an edge. Each set of voxels are proofed for this gradient step until 
returning to the starting voxel [147,248]. While the ROIs, thresholds, contour detection 
algorithms and filters vary across the Stratec protocols (I-V), they all calculate soft-tissue 
values in a similar fashion by identifying tissue boundaries and then subtracting area and 
content values to isolate the tissue (muscle, fat or bone) of interest. The derivation of 
  45 
Table 2: Summary of Image Analysis Settings  
Protocol Outcomes Region of Interest Voxels (mg/cm3) Algorithm(s) Median Filters 
XCT I Subcutaneous Fat Entire Image Matrix -40 to 39 Contour Mode 3 3x3, 5x5, 5x5 
 Muscle Entire Image Matrix 40 to 279 Contour Mode 3 3x3, 5x5, 5x5 
 Bone Entire Image Matrix ≥280 Contour Mode 1 3x3, 5x5, 5x5 
      
XCT II Muscle Entire Image Matrix 40 to 279 Contour Mode 3 3x3, 5x5 
 Bone Entire Image Matrix ≥280 Contour Mode 1 3x3, 5x5 
      
XCT III Muscle Entire Image Matrix 40 to 279 Contour Mode 1 3x3, 5x5 
 Bone Manual Trace T/R ≥280 Contour Mode 1 None 
 Bone Manual trace F/U ≥280 Contour Mode 1 None 
    
 
 
XCT IV Subcutaneous Fat Entire Image Matrix -100 to 39 
Contour Modes: 3, 31, 
1 
Peel Modes: 2, 2, 2 
3x3, 5x5, 5x5 
 Muscle Entire Image Matrix 40 to 149 
Contour Mode 31 
Peel Mode 2 
Separation Mode 4 
3x3, 5x5, 5x5 
 IMAT Entire Image Matrix 39 to -100 
Contour Mode 3 
Peel Mode 2 
Separation Mode 4 
None 
 Bone Entire Image Matrix >710 Separation Mode 4 3x3, 5x5, 5x5 
    
 
 
XCT V Muscle Manual trace N/A N/A None 
 Bone Manual Trace T/R N/A N/A None 
 Bone Manual trace F/U N/A N/A None 
    
 
 
BoneJ VI Subcutaneous Fat Entire Image Matrix -40 to 40 
Gradient Free 
Boundary Tracking 7x7 
 Muscle Entire Image Matrix 41 to 139 Gradient Free Boundary Tracking 7x7 
 IMAT Entire Image Matrix 40 to -40 Gradient Fee Boundary Tracking 7x7 
T/R = Tibia/Radius; F/U =Fibula/ T/R = Tibia/Radius; F/U =Fibula/Ulna; Manual Trace indicates that the region 
of interest was traced around the tissue by a technician prior to analysis, this is in contrast to protocols that use 
the entire image matrix and rely exclusively on a threshold-driven analysis to segment tissues. 
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muscle and fat area and density requires post-analysis calculation by the user. The exact 
calculations used for each protocol are provided in Appendix C. Muscle area (Figure 4: light 
gray area including internal dark gray spots) and content (used to define density) were 
derived by the area and content of all tissues greater than the muscle threshold (40 
mg/cm3), less tissues higher than the bone threshold (Figure 4: white/red areas). To 
determine muscle density (mg/cm3), muscle content (mg/cm) was divided by muscle area 
(cm2) (note that muscle area and density measures include IMAT). IMAT area was calculated 
as the area of tissue within the muscle area below the muscle threshold (Figure 4: dark gray 
spots). SAT area (Figure 4: dark gray border) was determined by the total limb area, minus 
the area of all tissues deeper than the SAT-muscle boundary.  
 
 
Figure 4: An unprocessed DICOM image of a pQCT lower leg scan (left) after a Stratec analysis (top) and 
subsequent filtering; BoneJ analysis (bottom). The portioned BoneJ image illustrates muscle area (red + green), 
inter-muscular adipose tissue (IMAT) (green) and subcutaneous adipose tissue (SAT) (purple). 
4.3.5! BoneJ Protocols 
The source code for the pQCT density distribution plugin for BoneJ (Version 1.3.11) is freely 
available online [252,255]. BoneJ’s soft-tissue analysis uses a 7x7 median filter to reduce 
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noise. The image is binarized according to the tissue thresholds selected. Starting in the top 
left corner of the image matrix, a gradient-free boundary tracking algorithm [260] searches 
for and traces the edge of the tissues of interest until it returns to its origin. For muscle (41 
to 139mg/cm3), the traced object with the largest area is retained along with any smaller 
objects that are greater than 1% of total limb size (Figure 4: crimson area). These muscle 
objects are then eroded by one pixel. For SAT (-40 to 40mg/cm3), the traced object with the 
largest area is retained and then eroded by three pixels to remove the skin (Figure 4: purple 
area). IMAT was identified by searching within the muscle objects for pixels in the fat density 
range (-40 to 40mg/cm3) (Figure 4: green area).  Muscle area and density, as well as IMAT 
and SAT area, were all provided automatically in the BoneJ analysis output.  
4.3.6! Statistical Methods 
Mean and standard deviations of the repeat measurement averages are reported for each 
outcome. Precision error was calculated as absolute values (SDRMS) and as a percentage of 
the sample mean (CV%RMS) [118]. The 95% LSC, a “criterion for the smallest change in 
measurement results that can be considered statistically significant with 95% confidence”, 
calculated by multiplying CV%RMS by 2.77 [59].  
Individual log-transformed CV% from repeat measures were utilized to compare the 
precision of image analysis protocols for each outcome. The data were checked for normality 
and outliers using skewness and kurtosis Z-scores as well as histograms and boxplots. Failed 
analyses were excluded from the precision error determination and comparison. All 
statistical comparisons were performed using shareware statistical software (R, version 
3.0.2, Foundation for Statistical Computing, Vienna, Austria, www.R-Project.org). Only two 
protocols (IV, VI) calculated IMAT area; therefore, they were compared using either paired t-
tests or a Wilcoxon Signed-Rank test if normality was violated. Outcomes produced by three 
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or more analysis protocols were compared using multilevel linear models and post-hoc Tukey 
contrasts (R-Packages “nlme” [261] and “multicomp” [262]). Both omnibus chi-squared and 
post-hoc P-values are reported. 
4.4! Results 
4.4.1! Image Analysis Failures  
While attempting to measure muscle and fat, protocols I and II accounted for all failures (3-
9% and 6-14%, respectively) (Tables 3 and 4).  
4.4.2! Precision Error Comparison   
In the lower leg (Table 3), there were no significant precision differences for muscle area 
across the six protocols (χ2 (4) = 5.82, P=0.325). Statistically significant differences existed 
in the precision of muscle density across the six protocols (χ2 (5) = 64.86, P<0.0001). Post-
hoc analysis revealed that protocol I (CV%RMS = 3.2%) was less precise (P<0.001) than all 
other protocols (CV%RMS = 0.7 to 1.9%) and protocol III (CV%RMS = 1.9%) was less precise 
than both protocol IV (CV%RMS = 0.7%, P<0.01) and VI (CV%RMS = 0.7%, P<0.05). For IMAT 
area, a paired t-test revealed that the precision error (CV%RMS = 3.3%) of protocol IV was 
lower (P<0.001) than protocol VI (CV%RMS = 28.0%). Three protocols reported SAT area (I, IV, 
VI), with precision differences observed across the protocols ( χ2 (2) = 9.04, P<0.011). Post 
hoc analysis revealed that protocol IV (CV%RMS = 3.1%) was significantly less precise 
(P<0.01) than protocol VI (CV%RMS = 2.4%).  
In the forearm (Table 4), precision of muscle area differed significantly across the six 
protocols (χ2 (4) = 37.55, P<0.0001). Post-hoc analysis revealed that protocol IV (CV%RMS = 
5.3%) was significantly less precise (P<0.01) than all other protocols (CV%RMS = 2.1 to 3.2%). 
The precision of muscle density differed across the six protocols (χ2 (5) = 29.33, P<0.0001). 
Post-hoc analysis revealed that protocol I (CV%RMS = 3.2%) was significantly less precise 
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(P<0.001) than protocols III, IV, V, and VI (CV%RMS = 1.4 to 1.6%). For IMAT area, a Wilcoxon 
Signed-Rank Test revealed that the precision error of protocol IV (CV%RMS = 7.0%) was 
significantly lower (P<0.001) than VI (CV%RMS = 42.2%). The precision of SAT area differed 
significantly across protocols I, IV, VI (χ2 (2) = 6.92, P<0.0315). Post-hoc analysis revealed 
that protocol IV (CV%RMS = 6.5%) was significantly less precise (P<0.05) than protocol VI 
(CV%RMS = 5.2%).  All other differences among analysis protocols did not reach statistical 
significance. 
Table 3: Lower Leg Precision 
Protocol 
N-
Pairs Mean SD CV%RMS SDRMS 
95% LSC 
(CV%*2.77)  
Contrasts 
P<0.05 
Muscle Area (cm2) !! !! !! !! !! !
I 32 58.3 8.5 3.3 1.9 9.2 N.S. 
II 30 57.5 8.1 3.7 2.1 10.3 N.S. 
III 35 62.9 10.6 3.5 2.2 9.8 N.S. 
IV 35 56.1 8.3 2.6 1.5 7.2 N.S. 
V 35 52.3 7.8 3.3 1.8 9.3 N.S. 
VI 35 59.4 8.7 2.5 1.5 6.9 N.S. 
Muscle Density (mg/cm3) !! !! !! !! !
I 32 70.7 3.4 3.2 2.3 8.9 II, III, IV, V, VI 
II 30 71.0 2.9 1.2 0.9 3.4 I 
III 35 67.6 3.4 1.9 1.3 5.3 I, IV, VI 
IV 35 71.6 2.4 0.7 0.5 2.0 I, III 
V 35 70.2 3.1 0.8 0.6 2.3 I 
VI 35 70.0 2.8 0.7 0.5 1.8 I, III 
IMAT Area (cm2) !! !! !! !! !! !
IV 35 16.4 2.7 3.3 0.5 9.2 VI 
VI 35 1.4 1.1 28.0 0.4 77.5 IV 
SAT Area (cm2) !! !! !! !! !! !
I 32 34.5 11.9 3.2 1.1 8.9 N.S. 
IV 35 31.0 11.3 3.1 1.0 8.6 VI 
VI 35 33.4 11.5 2.4 0.8 6.6 IV 
SD = Standard Deviation; CV%RMS = Root-Mean-Squared Coefficient of Variation; SDRMS = Root-Mean-
Squared Standard Deviation; LSC = Least Significant Change; P<0.05 = Tukey Contrasts; Least Significant 
Difference; IMAT = Inter-muscular Adipose Tissue; SAT = Sub-cutaneous Adipose Tissue; N.S. = Not 
Significant. 
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Table 4: Forearm Precision 
Protocol 
N-
Pairs Mean SD CV%RMS SDRMS 
95% LSC 
(CV%*2.77) 
Contrasts 
P<0.05 
Muscle Area (cm2)! !! !! !! !! !
I 34 24.0 4.1 3.2 0.8 8.7 IV 
II 33 24.0 4.0 2.7 0.6 7.5 IV 
III 35 25.6 4.4 2.1 0.5 5.9 IV 
IV 35 21.9 4.1 5.3 1.2 14.6 I, II, III, V, VI 
V 35 21.3 3.5 2.9 0.6 8.0 IV 
VI 35 24.4 4.1 2.7 0.7 7.6 IV 
Muscle Density (mg/cm3) !! !! !! !
I 34 74.2 2.6 3.2 2.4 9.0 III, IV, V, VI 
II 33 74.5 2.2 1.9 1.4 5.3 N.S. 
III 35 72.0 2.6 1.4 1.0 3.9 I 
IV 35 76.1 1.6 1.4 1.1 3.8 I 
V 35 73.5 2.2 1.6 1.2 4.5 I 
VI 35 72.3 1.9 1.5 1.1 4.1 I 
IMAT Area (cm2) !! !! !! !! !! !
IV 35 4.9 0.9 7.0 0.3 19.5 VI 
VI 35 1.0 0.5 42.2 0.4 116.8 IV 
SAT Area (cm2) !! !! !! !! !
I 34 14.4 6.3 6.4 0.9 17.6 N.S. 
IV 35 12.1 6.0 6.5 0.8 18.0 VI 
VI 35 14.1 6.2 5.2 0.7 14.4 IV 
SD = Standard Deviation; CV%RMS = Root-Mean-Squared Coefficient of Variation; SDRMS = Root-Mean-
Squared Standard Deviation; LSC = Least Significant Change; P<0.05 = Tukey Contrasts; IMAT = Inter-
muscular Adipose Tissue; SAT = Sub-cutaneous Adipose Tissue; N.S. = Not Significant. 
 
4.5! Discussion 
To date, a variety of image analysis protocols have been used to derive soft-tissue outcomes 
from pQCT images of the lower leg and forearm. This study is the first to report and directly 
compare the precision error values of previously reported image analysis methods to derive 
soft-tissue outcomes for both the lower leg and forearm. This study found that most 
protocols produced similar precision error values (apart from IMAT area) with subtle 
differences among the various outcomes.  
In the lower leg and forearm, most protocols (with the exception of IV in the forearm) 
provided comparable CV%RMS precision errors ranging between 2.1 and 3.7% for muscle
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area. These values are higher than those previously reported for children and college 
students (CV%RMS 1.4%) [51,70,86]. It may be that the discrepancy between these data and 
that of younger individuals is reflective of age-related morphological differences in 
musculature. One of these differences may be the amount of adipose within the muscle 
tissue, which pQCT-derived muscle area does not characterize. 
To estimate the relative amount of muscle adipose, pQCT-derived muscle density is a 
hydroxyapatite-calibrated analogue of X-ray attenuation, which is validated to estimate 
muscle lipids and triglycerides [124,125]. Muscle density combines all soft tissues between 
the inner edge of the subcutaneous fat and the outer edge of the bones as a composite 
index of IMAT and myocellular adipose [52]. Most protocols provided similar muscle density 
precision errors within a small range (0.7 to 1.9%) in the lower leg and forearm. Protocols IV, 
V and VI demonstrated precision values below 1% in the lower leg; the latter agreeing with 
that reported for children (0.9%) using protocol IV [51]. Both protocols IV and VI were also an 
improvement (P < 0.05) over protocol III (1.9%). In both limbs the largest error (P < 0.001) 
occurred with protocol I (3.2%). This contrasts with other protocol I results for the lower legs 
of middle aged (0.8%) [93], and older women (1.8%) [151] as well as the forearms of 
children (1.2%) [70]. This discrepancy, as well as the occurrence of failed analyses [151], 
suggests that investigators need to be cautious when using protocol I for deriving muscle 
density from pQCT scans in postmenopausal women.  
Another metric for muscle adiposity is inter-muscular adipose tissue (IMAT) area. A few 
pQCT studies have reported IMAT area or IMAT as a percentage of total muscle area [48,93]. 
Measuring the IMAT depot is challenging due to its small size relative to the pQCT voxels. The 
two protocols used to determine lower leg and forearm IMAT (IV and VI) used different image 
processing methods to help quantify IMAT area. Protocol IV quantifies the area of voxels 
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below 40mg/cm3 in an unfiltered muscle image, whereas protocol VI does this after pre-
processing the muscle with a 7x7 median filter. Precision error for the two protocols ranged 
between 3.3 and 42.2%.  Protocol IV was much more precise (3.3% and 7.0%) in the lower 
leg and forearm (P < 0.001), yet mean IMAT values were twelve and five times larger 
(respectively). Protocol VI results were similar to lower leg and forearm IMAT precision errors 
of 15.1% and 40.4% reported using a different filtering protocol in a sample of 
premenopausal women [93]. These results and the limited literature available [48,93] 
suggest that IMAT analysis protocols need further development and validation, with muscle 
density used in lieu of IMAT to quantify inter-muscular adipose tissue content.  
Several recent papers report using pQCT to quantify SAT area in the lower leg 
[52,70,72,83,86,91,104]; however, only three studies reported precision estimates for this 
outcome [70,86,90]. Lower leg and forearm precision ranged from 2.4 to 6.4% for SAT area. 
These lower leg results were comparable to children (3.2%) [70] and college students (2.7%) 
[86]. However, forearm SAT precision error was nearly twice that of the lower leg and the 
reported error (2.5%) for children [70]. This may be a reflection of both the increased risk of 
minor movement in the upper limb [70] which may be greater in older individuals [151] as 
well as differences in data acquisition protocols (e.g. time between repeated scans, 
differences in voxel size).  
Although observed differences in the precision errors across the pQCT protocols were 
small, a precision error of a mere 1% can affect the 95% LSC by a factor of 2.77. These small 
differences are important for quantifying modest musculoskeletal changes. For example, 
exercise interventions in older adults have reported between-group differences in muscle 
density (5.4%) [37] and IMAT (18%) [35] changes over 24 and 52 weeks respectively. Given 
the 95% LSC values below 5.4%, lower leg and forearm images analyzed using any method, 
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apart from method I, could reliably quantify changes in muscle density. Furthermore, with a 
95% LSC below 18%, method IV would be needed to reliably quantify a similar change in 
IMAT at the lower leg.  
This study has specific strengths related to sample population, sample size and 
scanning methodology. First, we have provided the first statistical comparison of precision 
errors across several pQCT analysis protocols for soft tissue outcomes clinically relevant for 
postmenopausal women [45,46,53]. Contrasted with results from younger participants 
[51,70,86], these data suggest that precision errors may be higher for forearm muscle area 
and SAT area in postmenopausal women. Other pQCT-derived soft-tissue precision studies 
have only reported lower leg precision values [86,90,151]. Second, this study met 
conservative recommendations (minimum of 27 degrees of freedom) for a precision error 
estimate within 30% of the mean error with an upper 90% confidence interval [118]. Failure 
to meet these recommendations can result in underestimation of precision errors [118]. In 
cases where the results included all 35 participants, precision error estimates can be trusted 
with a narrow 95% confidence interval [118]. Third, we collected images a mean of 9.7 days 
apart to avoid underestimating the precision error of soft tissues [86]. This is important 
because same day image collection can underestimate muscle and fat area precision errors 
due to enhanced technician recall when repositioning participants, or failure to capture 
between-day fluctuations in the precision error of the scanner [86].  
This study has specific limitations related to age-specificity and accuracy. 
First, these results are only applicable to older postmenopausal women (mean age: 73.7, SD 
7.2y). Second, the validity of pQCT measures of muscle and fat cross sectional area have 
been demonstrated against MRI [88]. QCT measures of muscle density and IMAT have been 
validated [124,125]; but these measures have not been directly validated with pQCT. 
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Comparison of pQCT-derived soft-tissue outcomes with MRI and MRS is a logical next step 
for the most precise image analysis protocols identified by this analysis. 
The results indicate that pQCT-derived muscle area, density, and SAT area can be 
determined in older adults with a CV%RMS ranging between 2.1 to 3.7%, 0.7 to 1.9%, and 2.4 
to 6.4% respectively. Precision for IMAT area varied considerably from 3 to 42%. While 
precision results were similar across most protocols, we have observed some subtle 
differences in methodology that can be used to aid both prospective and intervention studies 
of pQCT-derived soft-tissue outcomes in older adults. 
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5! Study Two:  
Monitoring pQCT-derived Muscle and Fat 
Outcomes in Older Women 
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5.1! Synopsis 
This chapter describes estimates of the annual changes in muscle and fat outcomes 
measured using pQCT, using data collected over 1 and 2 year intervals in older adult women. 
Precision error and annual change estimates were utilized to estimate prospective 
monitoring time intervals for pQCT-derived muscle and fat outcomes.   
5.2! Introduction 
The loss of muscle mass and function with age (termed “sarcopenia”) has been a vigorous 
area of aging research for over 20 years [8]. Sarcopenia increases the risk of physical 
disability, reduced quality of life, and can lead to death [13]. The etiology of sarcopenia is 
complex, and is primarily characterized by chronic loss of muscle tissue and function in older 
adults [166]. The ectopic accumulation of adipose tissue within muscle is thought to play a 
role in the chronic catabolic state observed with aging [164,184,263], and can be quantified 
in vivo with the use of clinical imaging techniques such as MRI and CT [164]. Clinical CT and 
MRI offer high-contrast images of soft-tissue compartments; but these tools often have 
limited availability and, in the case of CT, may have a high effective radiation dose [40]. 
Peripheral quantitative computed tomography scanners fill a musculoskeletal imaging niche 
between clinical CT and MRI [40]. Images of the upper and lower extremities can be acquired 
using pQCT scanners to quantify muscle size and adiposity [55,127], as well as 
subcutaneous adipose tissue (SAT) area [143]. Depot-specific adipose data are important 
because aging, sarcopenic obesity, and cachexia are each associated with different adipose 
redistribution patterns [113,166,169].  
In addition to providing insight into the composition of appendicular skeletal muscle, 
pQCT also has the capability to assess these measures with a high degree of precision 
[55,149,254]—a requisite for efficient longitudinal and intervention studies targeting muscle 
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and adipose tissues. Importantly, measurement precision, together with median annual 
changes, can be used to estimate MTIs between pQCT measurement occasions. MTIs 
provide a time estimate (in years) with 80% and 95% certainty, respectively, to detect 
progressive changes in pQCT-derived muscle and fat outcomes. MTIs with 80% certainty 
would be useful when the clinical benefits of the early detection of a trend in soft-tissue 
changes outweigh the need for statistical significance. These estimates allow follow-up 
measures to be performed within the optimal window for capturing clinically relevant and 
true biological changes, as well as minimizing participant radiation exposure and costs 
associated with repeated scanning in prospective studies. The ability of pQCT to detect 
changes in muscle or adiposity (in terms of both annual changes and MTIs) has not yet been 
reported in older adults. The purpose of this two-year prospective study was to: 1) assess the 
annual changes in pQCT-derived muscle area and density as well as IMAT and SAT at both 
the forearm and lower leg; and 2) estimate MTIs for each of the aforementioned muscle and 
adipose tissue outcomes in a cohort of older community-dwelling women. 
5.3! Methods 
5.3.1! Participants 
Female participants aged >60 years old were recruited from the Saskatoon cohort of the 
CaMOs. The CaMOs sample is described in section 4.1.3.1. All 336 eligible female 
Saskatoon CaMOs participants were mailed an invitation to participate in this study. Baseline 
measures for 147 participants that accepted the invitation have been previously described 
[53]. After one year, 115 participants returned for follow-up measurements. After two years, 
75 participants returned. To be eligible for this study, CaMOs participants had to have a 
lower leg circumference of less than 44cm (to fit the aperture of the scanner gantry) and be 
still for the scanning duration (approximately 4 minutes). Furthermore, valid forearm and/or 
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lower leg scans were required from at least two of the three annual imaging time points (T1, 
T2, or T3) for inclusion. Participants with diabetes, neuromuscular disease (Parkinson’s 
disease, multiple sclerosis, or other), eating disorders, immobilization (defined as 
confinement to a bed, wheelchair or cast for longer than one month) or a diagnosis or 
treatment for cancer during in the past six years were excluded from this analysis. All 
scanned participants were assigned a number and then sub-sampled using a random 
number generator for repeat pQCT measurements to determine the precision of muscle and 
adipose outcomes. A total of 35 women underwent repeat pQCT imaging of their non-
dominant forearm and lower leg within an average 9.7 (SD 3.6) days, as previously reported 
[149]. The University of Saskatchewan Biomedical Research Ethics Board reviewed and 
approved this research in accordance with the 2010 Canadian Tri-Council Policy Statement 
II: Ethical Conduct for Research Involving Humans. All participants provided written, informed 
consent. 
5.3.2! Descriptive Measures - Anthropometrics 
To characterize the sample, participant age, height (cm), weight (kg), and BMI (kg/m2) were 
assessed. Height was measured using a wall-mounted stadiometer (Holtain Ltd., Crosswell, 
Wales, UK) accurate to ± 1 mm and weight (in slacks and a t-shirt) from a calibrated scale 
(Toledo Ltd., Columbus OH, USA) accurate to ± 0.1 kg. 
5.3.3! Descriptive Measures – Physical Activity & Strength 
To assess whether physical activity and strength declined following baseline measures, 
participants completed self-reported minutes of physical activity and SF-36 Health Status 
questionnaire data. As well, participants performed the TUG [264] and isometric handgrip 
strength tests.  
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Two trained research assistants conducted the TUG test. Precision error (CV%RMS) 
calculated from repeat measurements of 35 women was 5.4% in this cohort. The protocol 
involved rising from a chair, walking three meters, turning around, and returning to their seat 
in a seated position. Each participant was asked to walk at their usual walking pace. A 
stopwatch measured the time between the moment the research assistant said the word 
“go” to the moment the participant’s body resumed contact with the backrest of the chair. 
Participants were able to make use of the chair arms, as well as any walking aids they would 
normally use in their daily lives. Each participant was granted a practice trial to ensure they 
understood the test protocol, followed by three timed trials with short rest intervals. The 
fastest completion time was recorded.  
 For the grip strength measure, participants underwent maximal isometric grip 
strength testing on their non-dominant hand using a JAMAR Hydraulic Hand Dynamometer 
(Lafayette Instrument Co. Lafayette IN, USA). Each participant was seated, with their 
shoulders adducted, elbows flexed at 90 degrees and forearms in neutral according to the 
American Society of Hand Therapists recommendations [265]. Three, 3-second long maximal 
attempts occurred with a half minute break provided between attempts. The highest score, 
accurate to ± 1 kg, was recorded with a precision error (CVRMS%) of 11%. 
5.3.4!  pQCT Image Acquisition 
Scans were acquired on the non-dominant (self-reported) lower leg and forearm using an XCT 
2000 pQCT (Stratec Medizintechnik GmbH, Pforzheim, Germany). The XCT 2000 is calibrated 
to provide hydroxyapatite mineral equivalent tissue densities, such that adipose tissue has a 
density of 0 mg/cm3 and water 60 mg/cm3 [146]. All images were collected at a scan speed 
of 20mm/s with a voxel size of 400µm x 400µm x 2.4mm. For both the forearm and lower 
leg, a scout scan was conducted to set a reference line at the medial aspect of the distal 
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radial epiphysis and the distal tibia plafond, respectively. A single image was collected at the 
site corresponding to 65% of total radius length or 66% of the total tibia length proximal from 
the reference line. These sites are the two most commonly pQCT-imaged locations for 
muscle and are the approximate anatomical location of the greatest limb girths [266,267]. 
The imaging technician visually assessed image quality using a subjective criterion; if motion 
artifacts interrupted cortical bone, the scan was not used and acquisition was repeated. All 
scans were acquired by the same technician (AFW).  
5.3.5! Image Analysis 
All scans were analyzed using BoneJ Version 1.3.11; a plugin for the freely-available image 
processing software ImageJ 1.48q (National Institutes of Health, Bethesda MD, USA) 
[104,255]. This image analysis protocol was selected for its relatively high precision of soft-
tissue outcomes as compared to other previously published pQCT image analysis techniques 
[149].  We used an upper threshold of 139mg/cm3 for soft-tissue to minimize the 
occurrence of rare tissue segmentation errors in older adult cohorts. The specifics of this 
image analysis technique and the parameters used are described elsewhere [149]. The 
automated image analysis software calculated muscle area and density as well as 
intramuscular adipose tissue (IMAT) and SAT areas for each scan.  
Automated contour detection algorithms did not always succeed in correctly 
identifying soft tissue boundaries; therefore, each analyzed image was visually inspected for 
errors using the BoneJ visual result output. All images were graded by two blinded 
technicians (AFW, CB) for severity of motion artifacts according to the visual inspection rating 
scale (1 to 5) developed by Blew et al. [108].  
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Figure 5: Visual inspection rating scale for femur (upper row) and tibia (lower row). Each score reflects the level 
of movement: 1 none, very minimal; 2 minimal; 3 moderate; 4 severe; 5 extreme. Reprinted with permission 
from Springer [108]. 
When two technicians’ ratings did not agree, a third blinded reviewer (SK) was consulted and 
the median value was reported. All scans rated >3 were excluded. To further minimize the 
effect of image quality on prospective soft-tissue changes, baseline and follow-up images 
that differed by more than one grade were also excluded.  
5.3.6! Statistical Methods 
For all participants, the longest available time between measures was utilized to determine 
annual change. This approach was taken to maximize both the observation time and sample 
size to provide accurate estimates of change [254].  Annual percentage change values were 
calculated by subtracting (adjusted) 1-year follow-up values from baseline values, and 
represented as a percentage change from baseline. To assess which outcomes actually 
changed, baseline and (adjusted) follow-up measures were statistically compared using IBM 
SPSS Statistics Version 22 (IBM, Armonk NY, USA). Skewness and kurtosis Z-scores as well 
as histograms and boxplots were used to check the data for normality (Z<1.96) and outliers 
(Z>2.58). Non-normal data was log-transformed, and re-checked for normality. Normally 
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distributed outcomes and transformed outcomes were compared using paired t-tests. Where 
log-transformation failed, the original data were compared using a Wilcoxon Signed-Rank 
test.  
 MTIs were defined as the ratio of measurement precision errors (specifically 80 and 
95% LSCs) to median annual percent changes. These two intervals represent the 
longitudinal sensitivity of pQCT measures, and estimate the time needed for 50% of the 
population to demonstrate age-related changes exceeding the instrument and operator’s 
measurement error [59]. For this study, LSCs from the related precision study of 35 women 
[149] were used to calculate MTIs. In this previous study, LSC was calculated based upon 
root-mean-squared coefficient of variation (CV%RMS) precision errors and an adjusted Z-score 
for the selected level of statistical confidence (Z = 1.8 for a two-tailed confidence of 80%; or 
Z = 2.77 for a two-tailed 95% confidence) via the equation LSC = Z-score x CV%RMS [59,149]. 
5.4! Results 
Baseline and follow-up data for a total of 108 and 120 valid forearm and lower leg  scans 
were collected (Figure 6). Of those with forearm scans, 22 were ineligible due to health 
conditions and 9 were excluded due to motion artifacts. Of those with lower leg scans, 24 
were ineligible due to health conditions and 4 were excluded due to motion artifacts. Data 
collected from a total of 97 participants were analyzed, for an overall average of 1.7 years 
(SD 0.6) of observation. 
Annual changes in height (-0.3 cm, P<0.001), and self-reported physical activity (-
3min/day, P<0.01) occurred over this time but they were not correlated with changes in 
muscle area, muscle density, SAT or IMAT area. Weight, BMI, TUG test time, grip strength, 
and SF-36 Health Status Score did not demonstrate an annual change (Table 5). The median 
annual change in forearm muscle area was -0.81% per year (P<0.001) (Table 2). In the 
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Figure 6: Flow chart of the image analysis process. Participants were excluded if they indicated the presence of 
diabetes, neuromuscular disease (Parkinson’s disease, multiple sclerosis, or other), eating disorders, 
immobilization >1 month or cancer diagnosis or treatment within the previous 6 years. Image motion artifacts 
were rated on a scale of 1 (none) to 5 (extreme) according to the subjective criteria provided by Blew et al.  
[108]. Scans rated 4 (severe) or higher were not considered valid. Scans collected at two of the three time 
points (T1, T2, or T3) were analyzed for annual changes in soft-tissue outcomes if they were rated similarly or 
within <2 scores.  
lower leg, muscle area change was -1.23% per year (P=0.004). No annual change was 
observed in muscle density, IMAT or SAT at either site (Table 6).  
 The MTI results estimate that clinically relevant and significant reductions in forearm 
muscle area could be detected in half of the older female adult population after 6 and 9 
years of follow-up respectively (Table 5). In the lower leg, a decline in muscle area and   
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Table 5: Baseline and Annual Follow-Up Participant Characteristics!
 
density could be detected within 4 and 6 years using pQCT (Table 6). MTIs for forearm 
muscle density, IMAT and SAT measures ranged between 18 and 143 years (Table 6). 
5.5! Discussion 
This is the first study to estimate annual changes and MTIs for pQCT-derived muscle and 
adiposity measures in community-dwelling older women. Robust estimates of the years of 
observation required to observe real, biological changes in muscle area and density using 
pQCT will assist with the planning of aging cohort studies [35]. We observed annual declines 
in pQCT-derived muscle area by 0.8 to 1.2% in older women for estimated follow-up intervals 
of 4 to 9 Years. Using these rate-of-change values, we estimate that 6 to 9 and 4 to 6 years 
of age-related atrophy in forearm and lower leg muscle area are needed before a clinically 
relevant or biological difference could be detected in half the population. Statistically 
significant annual changes were not observed for muscle density, IMAT or SAT area.  
 
 
Baseline Follow-Up* 
 
  Mean SD Mean SD 
P-
Value 
N=97 
     Time Between Measurements (y) 1.7 0.6 
   Age (y) 74.5 7.8 
   Height (cm) 158.8 6.1 158.5 6.2 0.001 
Weight (Kg) 69.8 12.7 69.3 12.9 0.060 
Body Mass Index (Kg/m2) 27.7 4.7 27.5 4.7 0.266 
Physical Activity (min/day)** 20 24 17 19 0.011 
SF36 Health Status Score (Max=100)** 74 17 74 17 0.862 
TUG test (s)** 9.6 2.6 9.6 2.4 0.715 
Grip Strength (kg) 17.1 4.8 17.3 4.6 0.583 
Abbreviations: SD = Standard Deviation; TUG = Timed Up and Go.  
P-Values are from Paired T-tests unless indicated otherwise.  
*Values Adjusted to 1-yr of follow-up time.  
 **Wilcoxon Signed Rank Test.  
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Table 6: Estimated Annual Changes & Monitoring Time Intervals 
          Confidence Level 
Outcome N 
Baseline Follow-up* 
P-Value 
Median 
Annual 
Change (%) 
80% 95% 
Mean SD Mean SD 
LSC 
(%) 
MTI 
(y) 
LSC 
(%) 
MTI  
(y) 
65% Forearm            
Muscle Area (cm2) 77 24.9 3.1 24.7 3.3 0.001 -0.81 4.9 6 7.6 9 
Muscle Density (mg/cm3)** 77 72.4 2.1 72.2 2.1 0.370 -0.04 2.7 66 4.1 92 
IMAT (cm2) 77 0.9 0.5 0.9 0.5 0.751 -4.15 76 18 117 28 
SAT (cm2)  77 14 7.6 13.9 7.6 0.296 -0.10 9.4 94 14.4 143 
 
           
66% Lower Leg            
Muscle Area (cm2) 92 60.6 9.1 59.6 9.0 0.001 -1.23 4.5 4 6.9 6 
Muscle Density (mg/cm3) 92 70.3 3.0 70.0 3.1 0.271 -0.28 1.3 5 1.8 6 
IMAT (cm2) 92 1.4 1.4 1.4 1.2 0.839 -1.61 50 31 78 48 
SAT (cm2) 92 32.8 12.6 32.4 12 0.223 -0.24 4.3 18 6.6 27 
Abbreviations: SD = Standard Deviation; LSC = Least Significant Change; MTI = Monitoring Time Interval; IMAT = Inter-muscular Adipose 
Tissue; SAT = Subcutaneous Adipose Tissue.  
P-Values are from Paired T-Tests, unless indicated otherwise.  
* Values adjusted to 1-yr of follow-up time. 
**P-Values from a Wilcoxon Signed Rank Test.      
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To date, the majority of prospective muscle aging research has relied on DXA-derived 
lean mass [268-270] and clinical CT based measures of muscle area, SAT, and 
attenuation/density [28]. DXA-derived analogs of appendicular muscle size, specifically arm 
and leg lean mass are the most commonly cited. Changes in leg lean tissue mass have been 
reported as -0.15%/year (P<0.01) in healthy American women observed over 2 years [268], -
0.40 to -0.65%/year (P<0.001) in Japanese women observed over 6 years [269], and -
0.79%/year  (P<0.001) in Italian women observed over 5 years [270]. Similar to the muscle 
area results from this study, annual changes in arm lean mass were smaller than those 
reported for the leg [268-270]. The precision error (CV%RMS) of these outcomes was reported 
to be 10.9 and 2.7% for arm and leg lean mass, respectively [134]. Using these CV%RMS 
errors with previously-mentioned mean change values in older adult women [268-270], we 
can estimate DXA-derived leg lean mass MTIs to range between 9 and 50 years, and are 
likely even longer for arm lean mass (due to greater precision error). Similarly, 5 years of 
prospective clinical CT data in healthy American women aged 70-79 years of age 
demonstrated a -0.64%/year decline in thigh muscle area [28]. With a reported precision 
error of approximately less than 5% [25], we can estimate a substantially longer MTI of up to 
21 years for CT measures of the thigh muscle area.  These results suggest that pQCT-derived 
muscle area may be a more useful metric than CT when assessing prospective biological 
changes in appendicular muscle size with age. 
In this sample, muscle area changed concurrently with a decline in self-reported 
physical activity, but without changes in muscle density, IMAT, SAT area, weight (P=0.058), 
BMI, health status, or functional test performance. Functional test performances are known 
to vary with comorbidities such as arthritis and obesity [112]. Handgrip and TUG 
performances did not change despite a decline in forearm and lower leg muscle size. These 
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results support the notion that precise imaging-based measures may allow for the detection 
of changes in muscle, adipose and bone before changes in physical function become 
clinically evident [112]. Tools that can better evaluate and differentiate more specific body 
composition features (e.g., muscle area, muscle density/attenuation, IMAT) are necessary 
for the development of therapies targeting muscle and physical performance [112]. 
Recently, Murphy et al. [271] reported that older adults can transition between normal and 
pre-sarcopenic states; yet once sarcopenic they were unlikely to transition back to a more 
normal state. This emphasizes the need for early identification of persons at risk of adverse 
changes in muscle size and composition for preventive intervention. Clinical researchers can 
utilize MTI estimates to plan appropriate follow-up intervals when monitoring soft-tissue 
outcomes in older women. Conditions such as sarcopenic obesity and cachexia display 
secular trends in weight, muscle, and adipose loss which can obscure relationships between 
general body composition measures (BMI, total body fat percentage) and functional 
outcomes [13,113]. Clinical researchers can make use of LSC values to inform decision 
making when observing changes in body composition in response to conditions such as HIV-
associated lipodystrophy, cachexia, or the effects of treatments like bariatric surgery. Use of 
liberal (80% confidence) versus conservative (95% confidence) estimates will depend on the 
context, and relative importance of modifying clinical intervention before a statistical change 
is observed [59].  
There were no changes in SAT or IMAT in the forearm or lower leg. Static SAT values, 
concurrent with changes in muscle composition have also been reported at the mid-thigh in 
weight-stable 70-79 year old women [28]. Delmonico et al. [28], reported a 6% increase in 
the adipose infiltration of muscle tissue, regardless of changes in weight, muscle size or SAT. 
However, contrary to the clinical CT results of Delmonico et al. [28], we did not observe  
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Figure 7: Typical lower leg grayscale image collected using a Stratec XCT2000 peripheral quantitative 
computed tomography scanner (A).  The lower leg image is filtered and segmented by BoneJ (B) into 
subcutaneous adipose tissue (SAT; purple), muscle area (red + green), and inter-muscular adipose tissue 
(IMAT; green). 
changes in pQCT-derived IMAT. This discrepancy may be due to the different muscles imaged 
(the thigh has a larger IMAT depot than the lower leg) and both the inconsistency and 
imprecision of pQCT-derived IMAT [93,149]. The 0.4 mm in-plane pixel size and contrast of 
pQCT imaging makes measuring small IMAT areas challenging (Figure 7). We also analyzed 
images using another IMAT technique (Bone Diagnostic Inc., Fort Atkinson WI, USA) that does 
not utilize image filters [149,249]; despite that, these alternative measures did not change 
the results (data not shown). Thus, current pQCT image analysis techniques do not appear 
capable of reliably isolating IMAT from surrounding muscle tissue and require further 
development. The establishment of open-source pQCT image analysis software [251,255] 
increases the potential for improvement in pQCT-derived IMAT. These results support the 
suggestion that pQCT researchers should consider reporting muscle density [93,149], rather 
than IMAT [55], as a surrogate measure of muscle adiposity [127]. 
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Muscle density combines all soft tissues between the inner edge of the SAT and the 
outer edge of the bones as a precise [149] composite index of muscle adiposity [52]. 
Scanner attenuation or hydroxyapatite-calibrated tissue density is a validated, inversely 
related measure of tissue adipose content [55,124,125,127]. In this cohort, annual changes 
in muscle density were not significant, yet the high precision of pQCT-derived lower leg 
muscle density allows for estimated MTIs of 5 and 6 years. Therefore pQCT-derived lower leg 
muscle area and density may provide valuable insight into changes in muscle size and 
quality within the same 4 to 6 year time interval. Median annual percentage change values 
for forearm muscle density did not yield useful MTIs. The data here do not offer a concrete 
explanation for this upper and lower limb discrepancy. However, these findings may be 
linked to observations of greater skeletal muscle loss in the lower body [113] and previously 
demonstrated differences between lower and upper body neuromuscular properties and 
performance with age [272-274].  
This study has several strengths related to sample, scanning and analysis 
methodology. First, we prospectively measured a sub-sample of a well-described population-
based Canadian cohort [253]. The TUG test and grip strength results of this sub-sample are 
characteristic of normative reference values for normal, unimpaired older women [264,275]. 
Furthermore, in an attempt to isolate natural age-related changes in muscle we have 
excluded women with chronic conditions (i.e., immobilization, eating disorders, 
neuromuscular diseases, diabetes, cancer) that are known to accelerate muscle loss. 
Second, the precision error estimates for measures included in this study exceed 
conservative recommendations (minimum of 27 degrees of freedom) for robust CV%RMS 
values [149]. These precision error estimates were determined with 35 degrees of freedom, 
in randomly selected participants sampled from this same cohort and therefore can be 
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trusted within a narrow 95% confidence interval [118]. Furthermore, the repeat images 
utilized were collected a mean of 9.7 days apart to avoid underestimating the precision error 
of soft tissues [86]. This is important as same-day image collection can underestimate 
muscle and adipose tissue area precision errors due to enhanced technician recall when 
repositioning participants, or failure to capture between-day fluctuations in the precision 
error of the scanner [86]. Third, we have carefully minimized the risk of erroneous soft-tissue 
changes from image artifacts. This was achieved through the application of a standardized 
motion rating scale [108] by up to three independent observers. This conservative quality 
assurance process excluded low quality images and did not analyze prospective images that 
differed by more than one motion rating increment. Finally, we utilized data from two-year 
observation periods when both the participation rate and image quality allowed us to do so. 
This provided a more robust estimate of annual changes than a reliance on shorter 
observation periods [59].  
This study has specific limitations related to age-specificity and accuracy. First, these 
results are only applicable to older women and the cohort they were sampled from was 
based on an urban population that is predominantly Caucasian. Furthermore, this voluntary 
sub-project ran between the scheduled Year 10 and Year 16 follow-up periods of the CaMOs 
study. Thus, it is not possible to nest this sub-sample within previously collected CaMOs data 
for a direct comparison of the characteristics of non-respondent CaMOs peers. As such, 
selection bias for healthier participants cannot be ruled out. Therefore, this analysis may 
underestimate the magnitude of soft-tissue changes and subsequently overestimated MTIs. 
Thus, these findings likely provide conservative estimates to assist the design of 
interventions and prospective studies in community dwelling older women. Furthermore, 
unrecorded behavior modifying comorbidities (i.e. arthritis, peripheral artery disease, etc.) 
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may have influenced these soft-tissue change estimates. Lastly, beyond excluding 
participants with self-reported eating disorders, the nutritional status of participants was not 
monitored during this period of observation. This is important because nutritional deficits are 
considered to be a secondary cause of sarcopenia [166], a potential confounder for this 
data. However, the use of median annual change values to calculate MTIs minimizes the 
effect of outliers and acute behavioural variability in these estimates; better reflecting the 
naturally occurring annualized changes in the cohort.  
In conclusion, researchers can reasonably expect annual age-related changes of -0.8 to 
-1.2%/year in pQCT-derived forearm and lower leg muscle area. Accounting for measurement 
precision error, researchers can reasonably expect to detect declines in pQCT forearm 
muscle area within 4 to 9 years and lower leg muscle area and density within 4 to 6 years in 
community-dwelling Caucasian women >60 years. 
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6! Study Three:  
Lower Leg Muscle Density is 
Independently Associated with Fall 
Status in Older Adults 
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6.1! Synopsis 
This chapter describes an analysis of the associations of pQCT derived muscle density, 
health outcomes, and functional mobility to fall status. Muscle density is associated with fall 
status, independent of biologically relevant covariates and functional mobility, which 
suggests that it may serve as an important biomarker for fall risk and musculoskeletal health 
in older adults. 
6.2! Introduction 
Falls are the leading cause of non-fatal emergency room visits in the US [58], and the 
primary cause of hip fractures in adults greater than 65 years old [57]. Approximately one 
third of older adults report a fall each year, and 20% of falls require medical attention 
[213,241]. Older, community-dwelling adults who fall cost heath care systems an average 
(US) $3,476; in cases where surgery and/or hospitalization are required, costs can rise to 
approximately $26,483 per individual [222]. The need for research on fall etiology is 
accentuated by age-adjusted data suggesting the rate of fall-induced injury is increasing 
[224].  
Falls are multi-factorial events caused by a combination of demographic, 
environmental, behavioral, and sensorimotor factors [241]. Among these, the strength and 
power of lower leg muscles are major contributing factors for falls, postural stability, and 
balance recovery in older adults [239,276,277]. Aging muscle undergoes changes in 
composition, defined by a decline in lean mass and an increase in adipose and non-
contractile tissue [164]. Increased quantities of muscle adipose may contribute to the 
catabolic state observed in muscle with age owing to the secretion of pro-inflammatory 
cytokines which stimulate muscle catabolism [181,182,184]. The relative amount of intra- 
and inter-muscular adipose can be quantified using imaging techniques such as MRI and CT.  
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Similar to CT attenuation values [124] pQCT-derived density measures are inversely 
related to lipid content, and approximately 50% of the variance in muscle density is 
explained by inter- and intra-muscular adipose tissues [55]. In older individuals, muscle 
adiposity has been linked to reduced lower extremity performance as well as muscle torque 
[23,24]. Two large prospective studies on aging, the Health Aging and Body Composition and 
the Invecchiare in Chianti Studies both revealed that adiposity (percent body fat, muscle 
density) and physical performance (walking speed, chair stand ability) but not lean mass, 
muscle size, or strength were risk factors for disability in healthy, older adults [26,27]. There 
is a growing body of evidence that suggests muscle adiposity and associated functional 
deficits manifest in clinically significant fall-related outcomes. Older persons with low muscle 
attenuation (which reflects higher adiposity) are 50 - 80% more likely to develop mobility 
limitations [24], and are at a greater risk of fracture [30,31,187,188], disability [26,27] and 
hospitalization [29]. 
Recent results from our lab found pQCT-derived muscle density to be significantly lower 
in the legs of well-functioning older women who reported one or more falls in the past year 
when compared to controls matched for age, BMI, and general health status [53]. 
Furthermore, no significant difference on the TUG test was observed between fallers and 
non-fallers, despite this functional mobility test consisting of both walking speed and chair 
rise components [53,264]. The association between lower leg muscle density (a surrogate of 
fat infiltration) and falls has not been previously described in the literature. Furthermore, the 
role of functional mobility in the association between muscle density and falls is not known. 
Therefore, the primary objective of this study was to explore the relationships of muscle 
density, functional mobility, and health-related factors to fall status. The primary hypothesis 
was that muscle density would be associated with fall status after adjusting for age, sex, 
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BMI, general health status, diabetes, a number of pertinent comorbidities, and functional 
mobility. The secondary objective was to determine the independent and combined 
relationship of muscle density and functional mobility to fall status after adjusting for health-
related factors. The secondary hypothesis was that models which include both muscle 
density and TUG test time will have a better fit with the data than models that include these 
factors separately. 
6.3! Methods 
6.3.1! Participants 
Participants aged ≥60 years were recruited from the Saskatoon cohort of CaMOs as 
described previously. All 501 eligible CaMOs participants were mailed an invitation to 
participate in this study. Eligibility criteria, recruitment and measurements for 147 female 
participants have been previously described in detail [53]. For these analyses, an additional 
43 males were recruited a year later using the same methodology. The University of 
Saskatchewan Biomedical Research Ethics Board reviewed and approved this research 
(BIOREB 10-83), and all participants provided written informed consent. 
6.3.2! Descriptive Measures 
To characterize the sample, fall status was determined by a response to the retrospective fall 
recall question: “have you fallen in the previous 12-months?”. Defined according to the 
Prevention of Falls Network Europe Consensus as ‘‘an unexpected event in which the 
participants come to rest on the ground, floor, or lower level’’ [226]. Retrospective fall recall 
results demonstrated good agreement (Kappa = 0.77), when repeated an average of 9.7 
(3.6) days apart in a random sub-sample of 35 female participants. 
Participant age (y), height (cm), weight (kg), BMI (kg/m2), hand grip strength (Kg) and 
SF-36 Health Status questionnaire data were recorded. Height was measured using a wall-
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mounted stadiometer (Holtain Ltd., Crosswell, Wales, UK) accurate to ± 1mm and weight (in 
slacks and a t-shirt) from a calibrated scale (Toledo Ltd., Columbus OH, USA) accurate to ± 
0.1 kg. Body mass index (kg/m2) was derived from height and weight measures. Isometric 
grip strength measures of the non-dominant hand were collected using a JAMAR Hydraulic 
Hand Dynamometer (Lafayette Instrument Co. Lafayette IN, USA) according to American 
Society of Hand Therapists recommendations. The highest score from three, 3-second long 
maximal attempts accurate to ± 1 kilogram was recorded with a precision error (CVRMS%) of 
11%. Confounding medical conditions for muscular health including diabetes, 
neuromuscular diseases (NMD; Parkinson’s, Multiple Sclerosis, or other), osteoarthritis, 
eating disorders, and immobilization or a diagnosis of cancer in the past six years were 
recorded. 
6.3.3! Timed Up and Go Test 
Two trained research assistants conducted the TUG test. The precision error (CV%RMS) 
calculated from repeat measurements of 35 women in this cohort was 5.4%. The timed 
protocol involved rising from a chair, walking 3 meters, turning around, and returning to their 
seat, at their usual walking pace [264]. Participants were able to make use of the chair 
arms, as well as any walking aids they would normally use in their daily lives. Each 
participant was granted a practice trial to ensure they understood the test protocol, followed 
by three timed trials with short rest intervals. The fastest completion time was recorded. 
6.3.4! pQCT Image Acquisition 
Scans were acquired on the non-dominant lower leg using an XCT 2000 pQCT (Stratec 
Medizintechnik GmbH, Pforzheim, Germany). The XCT 2000 is calibrated to provide 
hydroxyapatite mineral equivalent tissue densities, such that fat tissue has a density of 0 
mg/cm3 and water 60 mg/cm3. All images were collected at a scan speed of 20mm/s using 
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a voxel size of 400µm x 400µm x 2.4mm. A single image was collected at the site 
corresponding to 66% of the total tibia length proximal from a reference line at the medial 
aspect of the distal tibia plafond. This is the most common location for lower leg muscle 
scans, and the anatomical location of the greatest limb girth.  
6.3.5! Image Analysis 
All scans were analyzed using BoneJ Version 1.3.11; a plugin for the freely-available image 
processing software ImageJ 1.48q (National Institutes of Health, Bethesda MD, USA). We 
used density thresholds 40-139mg/cm3 to define muscle tissue. Technical aspects of the 
image analysis protocol have previously been described in detail [149]. The precision error 
(CV%RMS) calculated from repeated measurements of 35 women in this cohort was 2.5% for 
muscle area and 0.7% for muscle density [149]. 
All images were graded by the consensus of up to three blinded technicians for the 
severity (1 to 5) of motion artifacts according to the visual inspection rating scale developed 
by Blew et al. [108]. Scans rated >3 were excluded. 
6.3.6! Statistical Methods 
Faller and non-faller descriptive results and statistical comparisons were calculated for 
all variables. Categorical proportions were compared using Fisher’s Exact test. Non-normal 
data was log-transformed, and re-checked for normality. Normally-distributed outcomes and 
transformed outcomes were compared using independent t-tests. Where log-transformation 
failed, the original data were compared using the Wilcoxon Rank-Sum test. Logistic 
regressions were reported for fallers (1) and non-fallers (0). To test the associations of 
muscle density and functional mobility with fall status, forced entry multivariable logistic 
regression models were generated controlling for biologically relevant covariates: age, sex, 
BMI, general health status, diabetes and a number of pertinent comorbidities. Three models 
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were generated to test the predictive ability of 1) muscle density, 2) TUG test time and 3) 
both muscle density and TUG. Likelihood ratio tests determined if the model fit improved 
between independent (Models 1 & 2) and combined (Model 3) variables.  We report 
descriptive means, SDs, relative proportions (%) and counts, P-values, the area under the 
curve (AUC) for each multivariable model, as well as odds ratios (OR) and 95% confidence 
intervals [95% C.I.] for each predictor. Statistical significance was set at P <0.05. All 
statistical analyses were performed with IBM SPSS Statistics, Version 22 (IBM, Armonk NY, 
USA).  
6.4! Results 
A total of 190 older adults were recruited. A flowchart (Figure 8) details the participants 
included and excluded at each step of the analysis. A detailed description of the 183 eligible 
adults is provided in Table 7.  
Bivariate logistic regression analyses revealed significant odds ratios for several factors 
(Table 8). For every unit higher in general health status score, the odds of being a faller 
(defined as having reported one or more falls in the past year) was reduced by 3% (OR 0.97 
[95% C.I. 0.95 to 0.99]). For every second increase in TUG test result, the odds of being a 
faller increased by 16% (OR 1.16 [95% C.I. 1.03 to 1.30]). Similarly, for every mg/cm3 
increase in muscle density, the odds of being a faller decreased by 15% (OR 0.85 [95% C.I. 
0.75 to 0.95]). Being diabetic increased the odds of being a faller by 329% (OR 3.29 [95% 
C.I. 1.12 to 9.64]). 
Multivariable models controlled for biologically relevant confounders (age, sex, BMI, 
general health status, diabetes, number of comorbidities) to compare the ability of muscle 
density and TUG test to independently predict fall status (Table 9).  All three models provided 
  79 
 
 
Figure 8: Participant flow-chart detailing recruitment, bivariate, and multivariable analyses for models 1-3. 
Diabetes Q. = Questionnaire; 13 participants did not indicate a response and were excluded, along with 1 TUG 
test refusal. 
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Table 7: Descriptive Statistics  
 
Faller  
 (n=52) 
Non-Faller  
(n=131) P-Value 
Sex (male/female) 15/37 27/104 0.246a 
Age (y) 74.3 (8.6) 74.6 (7.6) 0.806b 
Height (cm) 161.9 (8.7) 162.0 (8.4) 0.867c 
Weight (kg) 75.8 (14.9) 71.7 (13.2) 0.095b 
BMI (kg/m2) 28.8 (5.1) 27.3 (4.3) 0.041b 
General Health Status (0 - 100) 64.6 (19.5) 73.0 (15.2) 0.022c 
TUG (s) 10.7 (3.1) 9.5 (2.4) 0.044c 
Grip Strength (kg) 19.7 (8.1) 20.4 (9.5) 0.584c 
Lower leg muscle    
Density (mg/cm3) 69.2 (3.5) 70.5 (2.3) 0.045c 
Area (cm2) 64.1 (11.2) 62.4 (11.2) 0.382b 
Comorbidities (count)    
Diabetes 15% (8) 5% (7) 0.034a 
NMD 4% (2) 10% (12) 0.356a 
Osteoarthritis 48% (25) 45% (59) 0.744a 
Eating disorders 2% (1) 0  (0) 0.284a 
*Immobilization >1month 6% (3) 2% (2) 0.096a 
*Cancer 10% (5) 6% (8) 0.354a 
Number of Comorbidities   0.307
a 
0 33% (17) 47% (61)  
1 52% (27) 41% (54)  
2 14% (7) 10.7% (14)  
3 2% (1) 2% (2)  
Abbreviations: BMI = Body Mass Index; TUG = Timed Up and Go; NMD = Neuromuscular 
Diseases. P<0.05 are bolded. P-Values from a Fisher’s Exact Test; b Independent T-Test; c 
Wilcoxon Rank-Sum Test 
*Diagnoses/occurrences within the previous 6 years 
 
acceptable discrimination with significant AUC values between 0.74 and 0.76, and 
significant (P<0.05) improvement over the covariates (Table 9 & Figure 9). In Model 1, higher 
muscle density (mean 70.2, SD 2.6mg/cm3) reduced the odds of being a faller by 19% (OR 
0.81 [95% C.I. 0.67 to 0.97). In Model 2, each second of TUG test time (mean 9.8, SD 2.6s) 
independently increased the odds of being a faller by 17% (OR 1.17 [95% C.I. 1.01 to 1.37]).
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Table 8: Bivariate Associations with Fall Status!
 95% C.I. 
 
Odds Ratio (eβ) Lower Upper 
Sex (female=0) 1.56 0.75 3.25 
Age (y) 1.00 0.96 1.04 
Height (cm) 1.00 0.96 1.04 
Weight (kg) 1.02 1.00 1.05 
BMI (kg/m2) 1.08 1.00 1.16 
General Health Status (0-100) 0.97 0.95 0.99 
TUG (s) 1.16 1.03 1.30 
Grip Strength (Kg) 0.99 0.96 1.03 
Lower leg muscle 
   Density (mg/cm3) 0.85 0.75 0.95 
Area (cm2) 1.01 0.99 1.04 
Comorbidities (reference=0) 
   Diabetes 3.29 1.12 9.64 
NMD 0.40 0.09 1.84 
Osteoarthritis 1.13 0.59 2.15 
*Immobilization >1month 4.98 0.79 31.49 
*Cancer 1.70 0.53 5.48 
Number of Comorbidities (None=0) 
   1 1.79 0.88 3.65 
2 1.79 0.63 5.15 
3 1.79 0.15 21.00 
Bivariate relationship between fallers (1) and non-fallers (0). There were not enough participants with 
eating disorders to generate a bivariate odds ratio. Bolded values indicate odds ratios with 95% C.I.s 
that do not include 1.00. Abbreviations: C.I.=Confidence Interval; BMI = Body Mass Index; TUG = 
Timed Up and Go; NMD = Neuromuscular Diseases. 
*In previous 6 years 
 
In Model 3 age independently reduced the odds of being a faller by 8% (OR 0.93 [95% C.I. 
0.87 to 0.99]). Model 3 included both muscle density and TUG test time as predictors, yet 
only muscle density independently reduced the odds of being a faller by 17% (OR 0.83 [95% 
C.I. 0.69 to 0.99]). Furthermore, when comparing Model 2 and Model 3, the addition of 
muscle density to a model that included TUG improved (Χ21=4.46, P=0.03) the overall fit with  
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Figure 9: Receiver operating characteristic plot for multivariate models discriminating fallers (1) from non-
fallers (0). Model values are the area under the curve. Null Model: age, sex, BMI, health status, diabetes, 
comorbidities; Model 1: Null Model + muscle density (MD); Model 2: Null Model + TUG test; Model 3: Null Model 
+ TUG test and muscle density. Likelihood Ratio Test Significant (P < 0.05) improvement from: * Null Model; 
**Model 2. 
the data compared to a model with just TUG test time. The addition of TUG test time (Model 
3) did not improve (Χ21 =2.81, P=0.09) overall fit when compared muscle density only 
(Model 1).
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Table 9: Multivariable Associations     
 Model AUCa 
95% C.I.  Odds  
Ratio (eβ) 
(eβ) 95% C.I. 
  Lower Upper Lower  Upper 
Null Model 0.71 0.63 0.80    
Age (y)    0.98 0.93 1.02 
Sex (female=0)    1.91 0.84 4.36 
BMI (kg/m2)    1.07 0.99 1.16 
General Health Status (0-100)    0.97 0.95 0.99 
Diabetes (no=0)    3.11 0.86 11.26 
Number of Comorbidities (none=0)       
1    1.59 0.67 3.77 
2    1.05 0.26 4.29 
3    0.91 0.06 14.96 
       
Model 1 * 0.73 0.64 0.81 
   Age (y) 
 
  0.94 0.88 1.00 
Sex (female=0) 
 
  1.74 0.75 4.06 
BMI (kg/m2) 
 
  1.05 0.97 1.14 
General Health Status (0-100) 
 
  0.98 0.96 1.00 
Diabetes (no=0) 
 
  2.62 0.70 9.86 
Number of Comorbidities (none=0) 
 
  
   1 
 
  1.63 0.68 3.92 
2 
 
  1.11 0.26 4.73 
3    1.63 0.10 27.03 
Lower Leg Muscle Density (mg/cm3) 
 
  0.81 0.67 0.97 
 
   
   
Model 2 * 0.73 0.65 0.82 
   Age (y) 
 
  0.96 0.91 1.01 
Sex (female=0) 
 
  2.01 0.87 4.68 
BMI (kg/m2) 
 
  1.06 0.98 1.15 
General Health Status (0-100) 
 
  0.98 0.96 1.00 
Diabetes (no=0) 
 
  3.03 0.81 11.28 
Number of Comorbidities (none=0) 
 
  
   1 
 
  1.73 0.72 4.13 
2 
 
  0.93 0.22 3.99 
3    1.23 0.07 20.67 
TUG test (s) 
 
  1.17 1.01 1.37 
  
  
   
Model 3 *, ** 0.75 0.66 0.83 
   Age (y) 
 
  0.93 0.87 0.99 
Sex (female=0) 
 
  1.85 0.78 4.37 
BMI (kg/m2) 
 
  1.04 0.96 1.13 
General Health Status (0-100) 
 
  0.98 0.96 1.01 
Diabetes (no=0) 
 
  2.63 0.68 10.13 
Number of Comorbidities (none=0) 
 
  
   1 
 
  1.75 0.72 4.25 
2 
 
  0.98 0.22 4.41 
3   1.99 0.12 33.73 
Lower Leg Muscle Density (mg/cm3) 
 
  0.83 0.69 0.99 
TUG test (s) 
 
  1.14 0.98 1.34 
Multivariable models discriminate fallers (1), from non-fallers (0). Bolded values indicate odds ratios with 95% C.I.s that do not 
include 1.00. Comorbidities included the presence or recent history of diabetes, NMD, osteoarthritis, eating disorders, 
immobilization, or cancer. Abbreviations: AUC=Area Under Curve; L.R.T.=Likelihood Ratio Test; C.I.=Confidence Interval 
aRange 0.5-1.0. Degree of discrimination: 0.7-0.8 acceptable, 0.8-0.9 excellent, 0.9-1.0 outstanding. 
Likelihood Ratio Test Significant (P < 0.05) improvement from: * Null Model; ** Model 2. 
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6.5! Discussion 
This is the first study to explore the relationship between muscle adiposity and fall status in 
older adults. The results indicate that every mg/cm3 increase in muscle density decreases 
the odds of being a faller by 17%, independent of age, BMI, health status, diabetes, the 
number of comorbidities and functional mobility. Muscle density was recently identified as a 
potential fall risk factor when comparing female fallers and controls matched for age, BMI 
and health status [53]. These results build on evidence from two clinical CT studies 
supporting a negative relationship between imaging-based measures of adiposity and fall-
induced fractures [30,31]. Adjusting for similar covariates, Lang et al. reported an increase 
in hip fracture odds of 40% per SD decrease in thigh muscle attenuation independent of age, 
sex, BMI, muscle size, strength, physical function, and hip bone mineral density [30]. Given 
that less than 10% of falls result in a fracture [241], these results advance the hypothesis 
that muscle density is relevant to the most common mechanism of serious injury in older 
adults [57,58,241]. 
Prospective studies have established muscle adiposity as a risk factor for incident 
disability [26,27], reduced gait [141], mobility [24], and fractures [30,187,188]. Thus, 
measures of muscle adiposity can serve as adjunct biomarkers of metabolic and 
musculoskeletal health. The clinical relevance of imaging-based measures of muscle 
adiposity among other fall factors [231] such as vitamin D status, fall history, balance, visual 
deficits, arthritis, depression, and cognition requires further study. These results indicate 
pQCT-derived muscle density to have a modest multivariate association with fall status even 
after accounting for variability in functional mobility. The excellent precision (CV%RMS=0.7%) 
of lower leg muscle density measures in older adults [149] may facilitate the longitudinal 
sensitivity and clinical utility of this outcome for monitoring changes in muscle composition.  
  85 
 Several physical activity and exercise studies suggest muscle adiposity to be an 
important and modifiable biometric target in older adults [35-37,184]. Taaffe et al. reported 
a 5.5% increase in thigh muscle density with 12-weeks of resistance training in older 
community-dwelling men and women [37]. In the context of the results, a lower leg muscle 
density increase of half that magnitude would reduce the odds of being a faller by more than 
30%. A recent randomized controlled trial demonstrated the specificity of 12-months of 
physical activity to reduce inter-muscular adipose, independent of total fat mass in sedentary 
older adults [36]. Most importantly, those physical-activity driven reductions in muscular 
adipose were independently associated with improved  physical performance [36]. These 
data further emphasize the importance of muscle adiposity as a biomarker in aging 
musculoskeletal health.   
Early identification of persons with greater muscle adiposity may improve their 
chances of a positive response to exercise; a recommended component for all multifactorial 
fall interventions [231]. Myosteatosis, “the accumulation of adipocytes within muscle” [167] 
and their secretion of pro-inflammatory cytokines exert pathophysiological effects which 
precede declines in muscular function with aging [182]. Pro-inflammatory cytokines promote 
peripheral insulin resistance, muscle protein catabolism [142,181], and decreased 
myofilament protein synthesis [181,182], increase oxidative stress, and reduce contractility 
and strength [142,181]. A heightened inflammatory state lowers the anabolic response to 
resistance exercise, making it more difficult for older adults to maintain and build muscle 
[181,182]. Older adult fallers with higher baseline levels of muscle adipose recently 
demonstrated blunted improvements in specific torque from three months of training with 
resistance, endurance and balance exercises [184].  
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The association between lower muscle density and fall status may also be a 
manifestation of the aging neuromuscular system. The degeneration of α-motoneuron axons 
inhibits the reinnervation of regenerating muscle fibres [173] and is related to muscle 
density [46]. Denervated “orphaned” fibres have two possible fates: 1) atrophy; signaling the 
differentiation of fibroblasts and adipocytes [175] or 2) reinnervation by a neighbouring 
motor-unit; resulting in the co-expression of contractile phenotypes [174], slowing contractile 
velocity, and reducing force and power. Thus, motoneuron degeneration reduces muscle 
density [46], and the power available for high-velocity fall-avoidance tasks such as 
recovering balance from a trip. 
The secondary objective of this investigation was to explore the independent and 
combined associations between muscle density and functional mobility to fall status. The 
TUG test is a composite measure of functional mobility [264], used to predict health decline 
and activities of daily living disabilities in community-dwelling older adults [278,279]. We 
demonstrated that the time to complete the TUG test was associated with fall status (OR 
1.17, [95% C.I. 1.01 to 1.37]), independent of age, sex, BMI, health status, diabetes, and the 
number of comorbidities. These results agree with prospective findings in a sample of 
community-dwelling Britons [280] who similarly demonstrated multivariate association 
between TUG and fall status (OR 1.09 [95% C.I. 1.00 to 1.19]) after adjustment for age, sex, 
number of comorbidities and falls in the previous year. The present analysis demonstrated 
that  the overall model fit improved with the addition of muscle density (P=0.03), but TUG 
was no longer an independent predictor of fall status (OR 1.14 [95% C.I. 0.98 to 1.34]). The 
proximity of the confidence interval to unity, and the relatively larger precision error (CV%RMS 
= 5.4%) of TUG measures, suggests that a larger sample may demonstrate an independent 
effect of functional mobility. Incident disability data indicates that the effect size for 
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performance on TUG-like functional mobility tasks may be smaller than measures of muscle 
adiposity in relatively healthy older adult cohorts [26]. Given that mean faller and non-faller 
TUG times were faster than many of the recommended fall risk cut-points for community-
dwelling older adults [281], it is also possible that a combined effect may predict fall risk in a 
sample with greater functional limitations and fall risk.  
This study has several strengths related to sample and analysis methodology. First, we 
have collected data from a sub-sample of a well-described randomly selected population-
based Canadian cohort [53,253]. Approximately 28% of the sample classified as fallers, 
similar to the estimated 29% of Canadian community-dwelling elders who experience a fall 
on an annual basis [213]. The TUG test results of this sub-sample are characteristic of 
normative reference values for normal, unimpaired older adults of this age [264]. Second, 
the multivariable analysis controls for several established confounding factors: age [28], sex 
[215], BMI [124], general health [53], and diabetes [137,167]. This study also has 
limitations related to the specificity of the sample and retrospective study design. First, these 
results were obtained from an urban sample of predominantly Caucasian older men and 
women. Furthermore, this voluntary sub-project ran between scheduled CaMOs study follow-
up periods. Thus it is not possible to directly compare participant characteristics with their 
non-respondent peers. Selection bias for healthier participants is likely given that age 
independently reduced the odds of being a faller in some models. Furthermore, the 
retrospective design did not allow us to determine whether the differences observed 
between fallers and non-fallers preceded or followed a fall event [239]. Lower muscle 
densities could also be a reflection of an injurious fall event and/or subsequent muscle 
deconditioning due to a fear of falling. The use of retrospective fall recall can minimize the 
magnitude of the observed effects through misclassification. A 23% underestimation of falls 
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has been reported for 12-month retrospective recall methods and approximately 6% of non-
fallers misclassify themselves in retrospective recall [282]. We provided the option of 
“unsure” on the falls questionnaire to mitigate the potential for misclassification. 
Nevertheless, the presence of non-differential misclassification, or the previously reported 
misclassification rates would reduce effect sizes, lending further support to the results. The 
robustness of these results will have to be tested through further investigation of muscle 
adiposity using prospective fall monitoring methods.  
This investigation provides further insight into the etiology of falls, by exploring the 
association between muscle density and fall status. The results expand upon the lower 
muscle density observed in female fallers [53], and supports indirect evidence of muscle 
adiposity as a risk factor for fall-related health outcomes such as frailty [45], fracture 
[30,31,187,188], hospitalization [29], and incident disability [26,27]. This research provides 
the impetus for the prospective study of muscle adiposity and fall risk. Muscle density is 
independently associated with fall status in a relatively unimpaired healthy older cohort, and 
the magnitude of this association is maintained after adjustment for biologically relevant 
covariates, as well as a measure of functional mobility. Thus, pQCT-derived muscle density 
may provide a physiological biomarker to further complement the assessment of 
musculoskeletal health and fall risk in well-functioning community-dwelling older adults. 
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7! General Discussion 
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7.1! Summary 
The overall aim of this thesis was to investigate the precision, annual changes, and 
longitudinal sensitivity of pQCT-derived muscle and fat outcomes, as well as explore the 
strength of their association with fall status in a cohort of community-dwelling older adults. 
The purpose of study one was to compare the precision of variations in image analysis 
protocols used to derive soft-tissue outcomes in older adults. This was achieved by first 
surveying the pQCT literature for studies that analyzed both muscle cross-sectional area and 
SAT, IMAT or muscle density. Protocols that were similar were sorted and given an identifier, 
and then each unique method was applied to a data set of repeat scans from 35 female 
CaMOs participants. The results of study one rejected the null hypothesis. Significant 
differences were detected among the precision errors for soft-tissue outcomes derived from 
each of the unique image analysis protocols. Precision errors appeared higher in the forearm 
than the lower limb, and varied considerably with the outcome. Muscle density provided 
precision error rates below 1%, whereas the precision error for IMAT was over 42%. Subtle 
differences existed in the precision of each of the methods applied. Protocols using the 
manufacturer’s recommendations appeared to experience more errors segmenting muscle 
from fat and bone when compared to third-party protocols and software. The precision error 
results corroborated with previously reported IMAT precision errors as high as 40% in middle-
aged women [93]. This was the first study to conduct a comparison of previously reported 
image analysis protocols. Furthermore, only two other studies [90,151] reported pQCT-
derived soft-tissue precision data for older adults, and only did so for some of the outcomes 
reported in this thesis. The results of study one provided the evidence necessary to select 
the most precise image analysis protocols for the prospective analysis of soft-tissue 
outcomes. This is important because the precision error is multiplied by a factor of 2.77 
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when assessing whether or not an observed change exceeds the error rate of a 
measurement tool with 95% confidence; and annual age-related changes in both DXA and CT 
measures of muscle mass and area have previously proven to be less than 1% [28,268-
270].  
Study two expanded on the results of study one, and focused on determining the 
annual changes and longitudinal sensitivity of pQCT-derived soft tissue outcomes by 
collecting and analyzing scans over one and two years. It was hypothesized that significant 
annual changes would be observed in pQCT soft-tissue outcomes. Statistically significant 
annual changes of -0.8 and -1.2% per year were observed in the muscle areas of the forearm 
and lower leg respectively. These findings were of a similar magnitude to declines reported in 
CT-derived muscle area and DXA-derived lean tissue mass for Italian and Japanese women, 
and showed a similar trend of greater changes in lower body muscles [268-270]. Significant 
annual changes were not detected for muscle density, SAT or IMAT, despite reports of 
changes in these soft-tissue parameters with aging [28,113,169,197]. Clinical CT studies 
that have demonstrated significant differences in IMAT tracked participants for 3 to 5 years 
[28,197], which may partially explain the failure to detect an effect in pQCT-derived IMAT and 
muscle density in study two.  Using both the precision data for soft-tissues and the annual 
changes observed, study two estimated MTIs wherein researchers could be either 80 or 95% 
certain that measured changes in muscle and fat tissues exceeded the limitations of both 
machine and operator error. These follow-up intervals can assist the planning of longitudinal 
studies that observe soft-tissue changes with pQCT. The more liberal MTI is an estimate 
wherein a clinical researcher could be 80% certain that observed changes are real biological 
effects and not an anomaly; whereas the more common 95% MTI provides an estimate of 
when observed changes would be statistically certain in 50% of the population [59]. Liberal 
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MTIs could be useful when monitoring clinically relevant trends that could influence the 
decision on whether or not a treatment or intervention should begin or be discontinued; 
situations where the benefits of pre-emptive action outweigh those of scientific certainty 
[59]. Simply having musculoskeletal imaging measures conducted can motivate people to 
modify their behaviour for better health [112]. The aim of estimating MTIs is to establish the 
most appropriate follow-up, so as to reduce measurement risk and cost burdens on both 
participants, clinics and/or laboratories [59]. The results of study two suggest that decreases 
in forearm and lower leg muscle area may be detected in 6 to 9 and 4 to 6 years 
respectively. Furthermore decreases in lower leg muscle density might also be detectable 
within 5 years. These estimates are likely conservative given the good physical function 
profile and potential for selection bias in this sample. Furthermore, in an attempt to generate 
estimates that characterize healthy aging; chronic conditions that can accelerate changes in 
muscle and fat outcomes were excluded from this analysis. Sub-populations with diabetes, 
neuromuscular disease, malnutrition, prolonged bed-rest or cancer will likely exhibit different 
(and likely shorter) MTIs. Although there are many MTIs reported for DXA and pQCT-derived 
bone outcomes [41,254], this thesis provides the first estimates generated for pQCT imaging 
based measures of muscle and fat outcomes in relatively healthy older adults.  
Lastly, study three involved an investigation of the bivariate and multivariable 
associations between fall status, pQCT-derived muscle density, and functional mobility.  
Study three correctly hypothesized that muscle density would be independently associated 
with fall risk after adjusting for biologically relevant covariates and functional mobility. The 
results demonstrated that for every unit increase in pQCT-derived muscle density (mean 
70.2, SD  2.6mg/cm3), the odds of having reported a fall dropped by 17% after adjusting for 
biologically relevant factors, and functional mobility performance. These results are similar to 
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odds ratios reported by Lang et al. [30,31] who observed a 40% decrease in other odds of 
hip fracture per SD increase in thigh muscle attenuation. Although every fall does not result 
in a hip fracture, falls are the primary mechanism by which older adults experience non-
violent hip fractures [57]. This investigation provides further insight into the etiology of falls, 
by exploring the strength of the association between muscle density and fall status. 
Research suggesting a relationship between muscle power, strength, and muscle adiposity 
[23,211] as well as the importance of lower body muscle strength in fall risk [239], may 
explain the mechanism that determines the association observed in study three. These 
results expand upon earlier research that reported lower muscle density in female fallers 
[53], and supports indirect evidence of muscle adiposity as a risk factor for fall-related 
health outcomes such as frailty [45], hip fracture [30,31], hospitalization [29], and incident 
disability [26,27]. The secondary hypothesis of study three was that models that included 
both muscle density and TUG would better fit the data than models that included them 
separately. This hypothesis was true when comparing the combined fit with a model that only 
included TUG and covariates, but was rejected when comparing the combined fit with muscle 
density. Put simply, muscle density improved the prediction of fall status after accounting for 
the variance explained by functional mobility, but improvements were not observed when 
adding functional mobility to models that already contained muscle density. Although the 
relative improvement in model fit is small, this result supports the prospective investigation 
of the predictive power and multivariate associations of muscle density and functional 
testing to falls in older adults.  
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7.2! Strengths and Limitations 
This research has several strengths and limitations. Among its strengths, the data were 
collected from a sample of relatively high-functioning community-dwelling older adult men 
and women. This sample is clinically relevant, because it can help us understand and 
prevent outcomes that may lead to a loss of independence, such as falling and fall-induced 
injuries. The use of common functional tests, such as the TUG and isometric hand grip 
strength, allowed for a comparison of this sample with age-appropriate reference values for 
healthy older adults [264,275]. This improved the ability to describe the participants in a 
functional context, and may also facilitate the pooling of data with other researchers. Lastly, 
the pQCT image analysis protocol utilized for this thesis was selected based on a comparison 
of the precision of all available options. As such, these results present estimates for pQCT 
derived muscle area, density, and SAT area in older adult women using the most precise 
protocol available.  
 There are several limitations of this thesis related to study design. These studies were 
part of a local subproject of a much larger national, multi-centre study. CaMOs participants 
volunteered to be involved in this research between their regular 5-year follow-up intervals 
for the CaMOs Study. As such, maintaining low participant burden was a significant design 
consideration that limited the number and complexity of outcomes measured with each 
participant’s appointment. Study two could have benefitted from the collection of behavior-
modifying comorbidity (i.e., arthritis, peripheral artery disease) and nutrition data when 
interpreting changes in soft-tissue outcomes over time. CaMOs questionnaires for self-
reported physical activity and simple functional tests such as handgrip strength and the TUG 
were utilized to measure behavior and physical function over time. The inclusion of a more 
detailed health condition questionnaire, objective measures of physical activity, and direct 
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measures muscle function may have yielded a more complete picture of the observed soft-
tissue changes. In study three, falls were ascertained via retrospective questionnaires to 
avoid participant fatigue and confusion, but are best recorded prospectively on calendars, 
diaries, or via regular telephone follow-ups. More detailed, prospective falls data would have 
facilitated analyses beyond the baseline measures, and investigations of recurrent fallers 
(who are more likely to have functional deficits). Lastly, because the baseline year (2010) for 
this sub-project did not coincide with CaMOs follow-up intervals, it is not possible to directly 
compare the participants in this thesis project with their non-responding cohort peers. Had 
this sub-project been nested, it would have been interesting to compare the groups on 16 
years of prospective health data to describe and assess the degree of health/survivor bias in 
the sub-sample.    
7.3! Conclusions 
In conclusion, this thesis demonstrated that pQCT imaging can provide precise 
measurements of muscle and fat outcomes in older adults. This is important for the study of 
muscular health and aging because the annual rate of change in these tissues can be quite 
low in older adults. Thesis data suggest a relative loss of muscle cross-sectional area of 0.8 
to 1.2% per year, with greater losses in the lower limb. Assuming that muscle tissues are not 
negatively impacted by other health conditions, biological changes can be detected with 80 
and 95% certainty within 4 to 9 years follow-up time. This data can assist with the planning 
of prospective research investigating the complex interactions between muscle, fat, and 
human health in aging. Lastly, this thesis demonstrated the strength of the association 
between one of these soft-tissue outcomes (muscle density) and falls, suggesting a 17% 
increase in odds of reporting a fall for every unit decrease in muscle density (mean 70.2, SD  
2.6mg/cm3). 
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7.4! Future Directions 
The clinical importance of the association between fall status and muscle density will need 
to be studied prospectively, and could be an interesting area of discovery. This thesis 
provides the methodological and effect-size data necessary to design a prospective 
investigation of this phenomenon using pQCT imaging. Currently, nutrition and physical 
exercise interventions are known to maintain [35] or improve muscle mass and physical 
function [7,32,165,166] and reduce muscle adiposity [36,37], increase insulin sensitivity 
[32,283], and reduce the number of falls and fall risk [241]. Very few studies provide a direct 
analysis of muscle adiposity and muscle torque [23,211] or power [211], even though there 
is considerable health outcome data (incident disability, reduced gait, mobility) indirectly 
suggesting a possible connection [24,26,27,141]. Future research that analyzes direct 
measures of human behaviour (i.e., multiphasic measures of activity), muscle function (i.e., 
muscle power) with anatomical (i.e., diffusion tensor imaging of muscle structure, measures 
of muscle size and adiposity), and physiological properties (i.e., mitochondrial energetics, 
inflammatory markers) will strengthen our understanding, and compliment research 
connecting changes in this organ with age. 
As we continue to study the etiology and prevention of sarcopenia and myosteatosis, 
tools that can provide further insight into the physiology of aging muscle and fat are needed 
[38,40,113,114]. More effective interventions will be possible through an enhanced 
understanding of the antecedents, natural history, and magnitude of changes in muscle loss 
and adipose infiltration observed with age [28,167]. Some of the data collected for this 
thesis was shared with a cross-disciplinary team of CaMOs Study investigators who have 
established a network of pQCT scanners in cities across Canada, and have been pooling 
imaging data with the goal of investigating the associations and development of muscle 
  97 
atrophy and adiposity, frailty, and fractures in aging Canadians. Furthermore, the Canadian 
Health Measures Survey recently acquired two pQCT scanners to collect musculoskeletal 
health data on Canadians as part of Statistics Canada’s nationwide health survey. The 
relative affordability and ability of pQCT to provide precise, tissue-specific estimates of 
adipose content and muscle size make it a compelling tool that could compliment MRI in the 
next generation of muscle, fat, and bone health research. There is growing musculoskeletal 
research interest in the interactions been muscle, fat and bone [284]. Muscle and bone 
tissues have long been known to interact biomechanically [285,286]. Recent studies of the 
coordination of shared paracrine and endocrine signals in the development, aging, and injury 
of these tissues has spurred new research directions in muscle, bone and fat cross-talk, as 
well as integrated approaches to developing treatments for sarcopenia and osteoporosis 
[284].  
 Pharmacological interventions are now turning their focus to the manipulation of 
myostatin levels and the neuromuscular junction [166] to reverse the effects of aging on 
muscle [32]. Relevant to these targets, pQCT has been an effective tool for the study of 
appendicular muscle size and adiposity with respect to muscle torques [126], in relation to 
motoneuron atrophy [46], as well as  spinal cord injury [287] diabetes [48,93,288], frailty 
[45], development of disability [27], fall risk [53], and fractures [54]. By no means a new 
tool, pQCT may still have an important role to play in our understanding of metabolic and 
neuromuscular health in aging.
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Appendix B 
Measurement of Muscle and Fat in Postmenopausal Women: Precision of 
Previously Reported pQCT Imaging Methods. As Published in the Journal Bone. 
  119 
  120 
!
  121 
!
The Article and the Supplemental Materials contain no libellous or other unlawful statements and do not contain any materials that violate any personal
or proprietary rights of any other person or entity.
I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in
the Article or the Supplemental Materials.
Except as expressly set out in this Journal Publishing Agreement, the Article is not subject to any prior rights or licenses and, if my or any of my co-
authors' institution has a policy that might restrict my ability to grant exclusive rights under this Journal Publishing Agreement, a written waiver of that
policy has been obtained.
If I am using any personal details or images of patients, research subjects or other individuals, I have obtained all consents required by applicable law
and complied with the publisher's policies relating to the use of such images or personal information. See http://www.elsevier.com/patientphotographs
for further information.
Any software contained in the Supplemental Materials is free from viruses, contaminants or worms.
If the Article or any of the Supplemental Materials were prepared jointly with other authors, I have informed the co-author(s) of the terms of this Journal
Publishing Agreement and that I am signing on their behalf as their agent, and I am authorized to do so.
For information on the publisher's copyright and access policies, please see http://www.elsevier.com/copyright. 
For more information about the definitions relating to this agreement click here.
I have read and agree to the terms of the Journal Publishing Agreement.
2nd February 2015 T-copyright-v19/2014
  122 
Appendix C  
Calculations for Muscle and Fat Outcomes from Study One 
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The detailed steps of the Stratec XCT and BoneJ analysis protocols for muscle density 
and area, as well as SAT and IMAT area are provided below.  
 
A)! Stratec XCT 
Stratec XCT was intended for bone outcomes and therefore the output will always be 
stated in bone terms (i.e. cortical area, content, and density); however, the values are only 
representative of the tissue corresponding to the thresholds employed. Modifying the 
analysis thresholds to reflect soft tissues (i.e. -40 or 40mg/cm3) is a common feature of 
most XCT soft tissue analyses.  
 
Filtering 
Stratec XCT median filters F03, F05, U01 and U04 are used. Every voxel within a filter’s 
density range is modified to the median value of the NxN mask. Filter F03 is a 3x3 mask that 
acts on voxels in the density range of -500 to 500mg/cm3, F05 a 5x5 mask with a range of -
500 to 300mg/cm3, and U01 a 7x7 mask with a range of -300 to 3000mg/cm3. The U04 
filter is a custom-made 3x3 median filter with a range of 120 to 2000mg/cm3 and is 
available from Bone Diagnostic Inc. [249]. 
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Appendix Table 1: Stratec XCT Image Analysis Loop Settings  
 
Method Outcomes Analysis Step # ROI Threshold Inner Threshold 
Contour 
Mode 
Peel 
Mode 
Cortical 
Threshold 
Inner Cortical 
Threshold 
Separation 
Mode Filters 2 
XCT I Muscle Area, 
Density, SAT 
Area 
1 Entire Matrix -40 
 
3 1 
   
F03F05F05 
 
2 Entire Matrix 40 
 
3 1 
   
F03F05F05 
 
3 Entire Matrix 280 
 
1 2 
   
F03F05F05 
            
XCT II Muscle Area, 
Density 
1 Entire Matrix 40 
 
3 1 
   
F03F05 
 
2 Entire Matrix 280 
 
1 2 
   
F03F05 
            
XCT III 
Muscle Area, 
Density 
1 Entire Matrix 40 
 
1 1 
   
F03F05 
 
2 Manual Trace T/R 280 
 
1 2 
    
 
3 Manual trace F/U 280 
 
1 2 
                
XCT IV 
Muscle Area, 
Density, SAT 
Area, IMAT 
1 Entire Matrix -100 40 3 2 149 40 4 F03F05F05 
 
2 Entire Matrix 40 40 31 2 710 40 4 F03F05F05 
 
3 Entire Matrix -100 40 3 2 710 -100 4 
 
 
4 Entire Matrix 40 40 1 2 -100 2000 4 U01U01U01U04 
            
XCT V 
Muscle 
Density 
1 Manual trace Muscle -100 
 
1 2 
    
 
2 Manual Trace T/R -100 
 
1 2 
    
 
3 Manual trace F/U -100 
 
1 2 
                ROI = Region of Interest; T/R = Tibia/Radius; F/U =Fibula/Ulna; Manual Trace indicates that the ROI was traced around the tissue by a technician prior to 
analysis, this is in contrast to methods that use the entire image matrix and rely exclusively on a threshold-driven analysis to segment tissues.   
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Calculations: 
Abbreviations refer directly from Stratec’s XCT output, but reflect tissues corresponding 
to the thresholds applied in Appendix Table 1: 
TOT_A = Total Area (mm2) 
TOT_CNT = Total Content (mg/mm) 
CRTSUB_A = Cortical and Subcortical Area (mm2) 
CRTSUB_DEN = Cortical and Subcortical Density (mg/cm3) 
CRT_A = Cortical Area (mm2) 
CRT_DEN = Cortical Density (mg/cm3) 
TRAB_A  = Trabecular Area (mm2) 
For all calculations “#1-4” denote the analysis step # listed in Appendix Table 1. 
  
  126 
Method XCT I 
SAT Area 
#1 TOT_A is skin, SAT, muscle, IMAT, bone and marrow area (mm2) 
#2 TOT_A is muscle, IMAT, bone and marrow area (mm2) 
Equation: 
(#1 TOT_A - #2 TOT_A) *0.01cm2/mm2 = SAT (cm2) 
 
Muscle Area 
#2 TOT_A is muscle, IMAT, bone and marrow area (mm2) 
#3 TOT_A is bone and marrow area (mm2) 
Equation: 
(#2 TOT_A - #3 TOT_A) *0.01cm2/mm2 = Muscle Area (cm2) 
 
Muscle Density 
#2 TOT_CNT is muscle, IMAT, bone and marrow total content (mg/mm) 
#3 TOT_CNT is bone and marrow total content (mg/mm) 
Equation: 
(#2 TOT_CNT - #3 TOT_CNT) *0.1cm/mm = Muscle Content (mg/cm) 
Muscle Content (mg/cm) / Muscle Area (cm2) = Muscle Density (mg/cm3) 
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Method XCT II 
Muscle Area 
#1 TOT_A is muscle, IMAT, bone and marrow area (mm2) 
#2 TOT_A is bone and marrow area (mm2) 
Equation: 
(#1 TOT_A - #2 TOT_A) *0.01cm2/mm2 = Muscle Area (cm2) 
 
Muscle Density 
#1 TOT_CNT is muscle, IMAT, bone and marrow content (mg/mm) 
#2 TOT_CNT is bone and marrow total content (mg/mm) 
Equation: 
(#1 TOT_CNT - #2 TOT_CNT) *0.1cm/mm = Muscle Content (mg/cm) 
Muscle Content (mg/cm) / Muscle Area (cm2) = Muscle Density (mg/cm3) 
Method XCT III 
Muscle Area 
#1 TOT_A is muscle, IMAT, bone and marrow area (mm2) 
#2 TOT_A is tibia or radius bone and marrow area (mm2) 
#3 TOT_A is fibula or ulna bone and marrow area (mm2) 
Equation: 
(#1 TOT_A – (#2 TOT_A + #3 TOT_A)) *0.01cm2/mm2 = Muscle Area (cm2) 
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Muscle Density 
#1 TOT_CNT is the total content of tissues that are not SAT (mg/mm) 
#2 TOT_CNT is the tibia or radius total content (mg/mm) 
#3 TOT_CNT is the fibula or ulna total content (mg/mm) 
Equation: 
(#1 TOT_CNT - (#2 TOT_CNT + #3 TOT_CNT))  *0.1cm/mm = Muscle Content (mg/cm) 
Muscle Content (mg/cm) / Muscle Area (cm2) = Muscle Density (mg/cm3) 
Method XCT IV 
Method IV attempts to correct values that may be distorted by the presence of positive 
and/or negative movement artifacts. Positive movement artifacts are distortions of the 
voxels that cause the density to be higher than they should be, and negative lower. If the 
artifact exceeds a tissue threshold, it can impact the soft-tissue area results. Furthermore 
skin is removed from SAT area. 
SAT Area 
#1 TRAB_A is the skin, SAT, marrow and negative movement artifact area (mm2) 
#2 TRAB_A is the marrow and negative movement artifact area (mm2) 
#4 CRT_A is the skin area (mm2) 
#3 CRT_A is the bone and marrow area (mm2) 
#2 CRT_A is the bone area (mm2) 
Equation: 
(#1 TRAB_A - #2 TRAB_A - #4 CRT_A – (#2 TRAB_A – (#3 CRT_A - #2 CRT_A))) 
*0.01cm2/mm2 = SAT (cm2) 
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Muscle Area 
#2 CRTSUB_A is the muscle, IMAT and bone area (mm2) 
#2 CRT_A is the bone area (mm2) 
#2 TRAB_A is the marrow and negative movement artifact area (mm2) 
#3 CRT_A is the bone and marrow area (mm2) 
Equation: 
(#2 CRTSUB_A – #2 CRT_A + (#2 TRAB_A – (#3 CRT_A – #2 CRT_A)))  
*0.01cm2/mm2 = Muscle Area (cm2) 
 
Muscle Density 
#2 CRTSUB_DEN is the muscle, IMAT, and bone density (mg/cm3) 
#2 CRTSUB_A is the muscle, IMAT and bone area (mm2) 
#1 CRT_A is the bone and positive movement artifact area (mm2) 
#1 CRT_DEN is the bone and positive movement artifact density (mg/cm3) 
Equation: 
((#2 CRTSUB_DEN * (#2 CRTSUB_A / #1 CRT_A)) – #1 CRT_DEN) / ((#2 CRTSUB_A – 
#1 CRT_A) / #1 CRT_A) = Muscle Density (mg/cm3) 
 
IMAT Area 
#3 TRAB_A is the SAT, IMAT, marrow, negative movement area (mm2) 
#1 TRAB_A is the skin, SAT, marrow, negative movement area (mm2) 
#4 CRT_A is the skin area (mm2) 
Equation: 
(#3 TRAB_A – #1 TRAB_A + #4 CRT_A)*0.01cm2/mm2 = IMAT Area (cm2) 
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Method XCT V  
Muscle Area 
#1 TOT_A is the manually traced muscle, IMAT, bone and marrow area (mm2) 
#2 TOT_A is the manually traced tibia or radius bone and marrow area (mm2) 
#3 TOT_A is the manually traced fibula or ulna bone and marrow area (mm2) 
Equation: 
(#1 TOT_A – (#2 TOT_A + #3 TOT_A)) *0.01cm2/mm2 = Muscle Area (cm2) 
Muscle Density 
#1 TOT_CNT is the manually traced muscle, IMAT, bone and marrow area content 
(mg/mm) 
#2 TOT_CNT is the manually traced tibia or radius bone and marrow content (mg/mm) 
#3 TOT_CNT is the manually traced fibula or ulna bone and marrow content (mg/mm) 
Equation: 
(#1 TOT_CNT - (#2 TOT_CNT + #3 TOT_CNT))  *0.1cm/mm = Muscle Content (mg/cm) 
Muscle Content (mg/cm) / Muscle Area (cm2) = Muscle Density (mg/cm3) 
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 B) BoneJ (Method VI) 
The source code [255] and description of the BoneJ outcomes can be obtained online 
[252]. No additional calculations necessary. BoneJ abbreviations are defined below.  
SubCutFatA [cm²] = SAT Area 
MuA [cm²] = Muscle Area 
MuD [mg/cm³] = Muscle Density 
IntraFatA [cm²] = IMAT Area 
 
BoneJ can analyze a batch of images with the appropriate macro, reducing the analysis 
time. We have appended the text, and instructions for use of the batch macro from our 
analysis on the following page. 
BoneJ Image Batch Analysis Macro 
Copy the code on the following page into the ImageJ Macro Text Editor Found in: 
Plugins > New> Macros >  
1) Make sure the text in the macro editor matches the text below. 
2) Replace the file directory and save directory paths with the paths to folders on your 
computer. (Of note, the example file path is for a Macintosh OS,  Windows users will 
need to use the appropriate file path for their system; i.e. C:\filefolder\) 
3) Hit Save 
To Run: 
Plugins> Macros> Select saved macro.txt file 
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macro "Batch Soft Tissue Analysis"{ 
 setBatchMode(true); 
 sourceDir = "/Users/imagefolder/"; //Replace this path with 
the path to the folder containing Stratec “.M01 or 02, 03, etc.” 
image files on your computer 
 visualDir = "/Users/imageexport/"; //Replace this path with 
the path to where you want to save the visualization images on 
your computer 
 parameterString = " air_threshold=-40.0 fat=40.0 
muscle_threshold=40.0 marrow_threshold=80 
soft_tissue_threshold=140 rotation_threshold=169.000 
area=550.0000 bmd=690.0000 roi_selection=Bigger 
soft_tissue_roi_selection=Bigger 
rotation_selection=According_to_Imax/Imin 
analyse_density_distribution analyse_soft_tissues 
suppress_result_image set_distribution_results_rotation_manually 
manual_rotation_[+-_180_deg]=90.0000 
save_visual_result_image_on_disk image_save_path="+visualDir; 
 files = getFileList(sourceDir); 
 for (i = 0; i<files.length;++i){ 
  showProgress(i+1, files.length); 
  run("Stratec pQCT", "select="+sourceDir+files[i]); 
  run("Distribution Analysis", parameterString); 
  close(); 
 } 
 setBatchMode(false); 
} 
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Appendix D 
Example: Calculating of Relative (CV%RMS) and Absolute (SDRMS) Precision Error
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  A B C D E 
1  Measure 1 Measure 2  Mavg Δmean Δmean^2 
2 Participant 1 25.5 26.1 25.81 -0.63 0.39 
3 Participant 2 30.2 31.9 31.07 -1.70 2.89 
4 Participant 3 18.8 20.8 19.80 -2.01 4.03 
5 Etc., … … … … … 
6  
 
Average 25.56 SDRMS 1.10 
7  
   
CV%RMS 4.32 
  
      Gluer 
Equation # 
[118] 
      C2-5 AVERAGE(A2:B2) 
    C6 AVERAGE(C2:C5) 
    D2-5 (A2-B2) 
    E2-5 D2^2 
   4b E6 (SDRMS) SQRT(SUM(E2:E5)/(2*COUNT(E2:E5))) 
 5 E7 (CV%RMS) (E6/C6)*100 
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Figure 2: Komolka et al. [122]              
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Figure 3: Lang et al. [30] 
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Figure 5: Blew et al. [108] 
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